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ABSTRACT 
Formation and Characterization of  
in vitro Bioengineered Neuromuscular Junction Models 
 
Surapon N. Charoensook 
 
In vitro models of the neuromuscular junction (NMJ) are emerging as a valuable tool to study 
synaptogenesis, synaptic maintenance, and pathogenesis of neurodegenerative diseases. Many 
models have previously been developed using a variety of cell sources for muscle and 
motoneurons, but the models can be further improved by integrating beneficial features to better 
mimic the native milieu of NMJ development. We created a functional in vitro model of NMJ by 
bioreactor cultivation of C2C12 myoblasts, transdifferentiated myocytes and stem cell-derived 
motoneurons with electrical stimulation. Proper coculture medium and electrical stimulation led 
to improved functional coupling between the emerging motoneurons and myocytes, as evidenced 
by mature cellular structures, increased expression of neuronal and muscular genes, 
clusterization of acetylcholine receptors (AChRs) in the vicinity of motoneurons, and the 
response of the coculture to glutamate stimulation. To validate the models and demonstrate 
utility for pharmacological testing, we analyzed the potency of the drugs that affect key 
pathways during NMJ signal transduction, including acetylcholine (ACh) synthesis, ACh 
vesicular storage, ACh synaptic release, AChR activation, and ACh inactivation in the synaptic 
cleft. The models properly responded to the drugs in a concentration-dependent manner. The 
proposed in vitro NMJ model could thus be used in pharmacological screening and controlled 
studies of neuromuscular diseases.  
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This dissertation amalgamates the results from doctoral research studies attempting 
to develop, optimize and characterize coculture systems of skeletal muscle and 
motoneurons for applications in neuromuscular interaction analysis and pharmacological 
testing. The Introduction will emphasize on the physiology and development of skeletal 
muscle, motoneurons and neuromuscular junction (NMJ) in order to provide a fundamental 
understanding of how these structures develop and function in living systems. The NMJ-
related diseases and the current advancement of NMJ in vitro models will also be 
discussed to highlight the necessity for more biomimetic culture models in future research.  
1.1 Skeletal Muscle 
 Skeletal muscle consists of highly organized, unbranched, contractile fibers 
facilitating the voluntary unidirectional contraction of the tissue. Each muscle fiber is a 
syncytium with nuclei and organelles located in the cell periphery because most of the 
intracellular space is occupied by the myofibrils. Myofibrils are comprised of elongated 
repeating contractile units called sarcomeres. Each sarcomere consists of a network of 
longitudinal filaments arranged in a regular pattern that gives the fiber its striated pattern. 
Different bands visible in the muscle fiber are due to variations in the refractive index of 
its myofibrils and the separation of different filament types [1] as shown in Figure 1. The 
isotropic bands mainly consist of thin filaments of actin that run spirally along a 
 3 
tropomyosin protein. One end of an actin filament is bound to a z disc and the other end 
extends into the anisotropic band where they interlock with thick filaments of myosin. 
 
 
Figure 1 Skeletal muscle structure 
Sarcomere shortening, which leads to muscle contraction, is initiated by an increase 
in cytosolic calcium ions (Ca2+), secreted from sarcoplasmic reticulum, upon the arrival of 
an action potential (AP) at the NMJ and the subsequent depolarization of the postsynaptic 
muscle membrane. Transverse tubules (T-tubules), which are invaginations of the 
sarcolemma, run perpendicular to the length of the fiber. These structures allow 
depolarization of the muscle membrane to penetrate rapidly to the center of the cell. In 
addition, T-tubules are heavily populated with L-type Ca2+ channels to ensure synchronous 
 4 
activation of sarcomere shortening across all the myofibrils in the muscle. Influx of Ca2+ 
binds to troponin complex and causes the conformational change of the actin-tropomyosin 
structure, allowing the myosin heads to bind to active sites on actin filament and pull two z 
discs closer together. When cytosolic Ca2+ ions are pumped back into the sarcoplasmic 
reticulum, the actin-tropomyosin structure returns to its original conformation, blocking 
myosin head binding and therefore relaxing the muscle. 
 
 
Figure 2 Molecular mechanisms during sarcomere shortening  
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Figure 3 Embryonic development of skeletal muscle 
Adapted from Buckingham, M. and F. Relaix. Annu. Rev. Cell Dev. Biol., 2007. 23: p. 649. 
Regarding to the embryonic development as shown in Figure 3, the mammalian 
skeletal musculature originally derives from the somites, paraxial mesoderm segments that 
form on either side of the neural tube [2]. Correct development of skeletal muscle is 
critically dependent on a family of basic helix-loop-helix transcription factors, Myf5, 
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MyoD, Mrf4 and myogenin, which are collectively termed the myogenic regulatory factors 
(MRFs), as well as the paired box (Pax) transcription factors Pax 3 and Pax 7 [2-4]. 
Initially, delaminating cells from the edges of the dermomyotome, the Pax 3/7 positive 
dorsal region of the somite, downregulate Pax 3, becoming myoblasts through Myf5 and 
Mrf4 activation [5]. Mrf4, MyoD and myogenin activity then promote differentiation of 
myoblasts into myocytes, which subsequently fuse into multinucleated myotubes. These 
myotubes mature into muscle fibers, forming a continuous layer within the embryo called 
myotome. Once formed, the myotome is post-mitotic since the muscle fibers present 
within it are multinuclear [5]. Further growth of the skeletal muscle tissue is thus 
facilitated by Pax 3/7 positive cells migrating out from the center of the dermomyotome as 
it loses its epithelial structure during somite maturation [6]. A substantial subpopulation of 
these proliferating cells gives rise to myogenic cells positive for Myf5 and MyoD, which 
are then capable of fusing with existing fibers as well as with each other, creating new 
fibers, and therefore facilitating further growth of the skeletal musculature [2, 5, 6].  
1.2 Motoneuron 
Motoneuron is characterized by the presence of an axon and dendritic tree. Its cell 
body is located in the spinal cord with an axon projecting outside the spinal cord to directly 
or indirectly control effector organs such as muscles and glands [1]. Incoming APs arrive 
via the dendrites and are propagated to the target tissue via the axon. The axon splits into 
many branches at its axon terminal, forming synaptic contacts with other cells. 
There are two main types of motoneurons: autonomic and somatic motoneurons. 
Autonomic motoneuron innervates smooth muscle or glands only by the intermediary of a 
 7 
 
Figure 4 Types of motoneurons 
postganglionic motoneuron located in an autonomic ganglion whereas somatic motoneuron 
directly synapses with striated muscle fibers by motor endplates. Therefore, only somatic 
motoneurons play a significant role in NMJ function. Somatic motoneurons are subdivided 
into alpha (α)-, beta (β)- and gamma (ϒ)-motoneurons. Individual muscles are composed 
of a mixture of fiber types, which can be grouped into two major categories: extrafusal and 
intrafusal. Extrafusal fibers are primarily responsible for skeletal movement whereas 
intrafusal fibers modulate the sensitivity of muscle to stretch [7]. α-motoneurons are the 
most abundant of these subtypes and they innervate the extrafusal muscle fibers 
responsible for triggering muscle contraction [8]. ϒ-motoneurons involved in motor 
control via the intrafusal fiber innervation whereas β-motoneurons innervate both fiber 
types and have a poorly understood role in regulating muscle contraction [8]. The 
collection of motoneurons responsible for innervating an individual muscle is termed a 
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motor pool. The motor pools are collectively located within the ventral horn of the spinal 
cord, arranged topologically to match the muscular layout of the organism [8].  
Developmentally, motoneurons are derived from the neuroepithelium and their 
embryonic differentiation is controlled by the notochord via Sonic hedgehog (Shh) activity 
[9]. Expression patterns of LIM homeodomain class transcription factors are believed to 
govern the developing motoneuron subtype identity which in turn dictates axonal trajectory 
from the neural tube. Axonal growth is controlled by a complex interplay of chemo-
attractants and repellents and allows for the targeted movement of the developing growth 
cone towards its specific muscle group [10]. Motoneurons facilitate the contraction of 
skeletal muscle by conveying efferent signals from the central nervous system to the NMJ. 
Chemical transmission across this synapse triggers contraction of the muscle fiber and is 
discussed in more detail in the next section.   
1.3 Neuromuscular Junction 
NMJ is the synaptic connection between motoneurons and skeletal muscle. 
Motoneurons reside in the motor columns of the ventral horn and each individual muscle 
fiber is innervated by the terminal branch of a single motoneuron. Initially, however, each 
muscle fiber develops synapses with multiple motoneuron axons. The elimination process 
occurs during the neonatal period, leaving each fiber innervated by a single nerve [11]. The 
elimination of poly-neuronal innervation is achieved in an activity-dependent and 
competitive manner and is believed to involve the activation of protein kinase C (PKC), 
mediated by the serine protease thrombin [12].  
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During development, NMJ forms in a series of elaborate signal interactions 
between axon terminals of motoneurons and excitable plasma membrane of muscle, 
requiring intricate communications of cytokines, growth factors and cellular structures [13, 
14]. The molecular mechanisms controlling NMJ formation are not completely 
characterized, but the process is believed to involve the activity of the muscle membrane 
bound receptor tyrosine kinase muscle-specific kinase (MuSK) [15, 16]. The MuSK gene 
promoter contains a sequence targeted by myogenin, thereby ensuring its upregulation 
during myoblast differentiation [17].  
Before innervation, MuSK initially binds to Wnt signalling proteins, which play a 
role in early AChR clustering [18, 19]. Wnts, secreted by the neuron growth cone, bind to 
MuSK and are thought to promote the activation of the cytoplasmic protein Dishevelled 
(Dvl) [20]. Dvl acts as a bridge molecule between MuSK and the p21 kinase PAK, 
allowing MuSK to regulate actin dynamics and thereby promote cytoskeletal changes to 
bring about AChR clustering [18]. These early clustering events do not dictate the location 
of NMJ formation because incoming spinal motoneuron axons tend to ignore most 
preexisting AChR clusters, instead forming synapses at new locations [21]. These 
primitive, Wnt-MuSK mediated, aneural AChR clusters form around the central region of 
the fiber and, while not the exact target of the developing neurite, are believed to play a 
role in axon guidance, ensuring the growth cone is directed to the center of the muscle 
fiber. Eventually, however, aneural AChR clusters have completely disappeared and all 
remaining AChR clusters are apposed by nerve terminals [22].  
Important molecular pathways linked to NMJ stabilization and formation include 
the agrin–muscle-specific kinase (MuSK), neuregulin (NGR-1)-erythroblastosis oncogene  
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Figure 5 Molecular pathways in NMJ formation and stabilization 
Adapted from Bloch-Gallego, E., Cell Mol Life Sci, 2015. 72(6): p. 1034 
B (ErbB), and ACh-AChR. Agrin, a polypeptide secreted by the motor axon terminal, 
binds to a preformed MuSK–lipoprotein receptor-related protein 4 (Lrp4) complex to 
promote MuSK transphosphorylation and cluster AChRs through the cytoplasmic linker 
protein rapsyn [17, 23-25]. It is an important inducer and a stabilizer of AChR clustering in 
the postsynaptic membrane [26, 27]. NGR-1, released by motoneurons, activates ErbB in 
the muscle membrane to potentiates AChR transcription in synaptic [14]. Both pathways 
comprise positive signals for NMJ assembly induction. In addition, ACh plays an 
important role in NMJ formation and stabilization. As motoneuron terminal makes 
synaptic connection with the plasma membrane of skeletal muscle, ACh released by the 
motoneuron induces a postsynaptic depolarizing potential, stabilizing previous AChR 
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clusters in the synaptic area and preventing AChR aggregation in extra-synaptic regions. 
Global AChR transcription is suppressed by ACh through myogenin inhibition [28, 29]. 
 
Figure 6 Important components of NMJ and neurotransmission process 
Neuromuscular transmission is triggered when an AP propagates to an axon 
terminal, causing an influx of Ca2+ through voltage-gated calcium channels and the release 
of an excitatory neurotransmitter acetylcholine (ACh) from synaptic vesicles. ACh diffuses 
though synaptic cleft and activates nicotinic acetylcholine receptors (AChRs) on the 
postsynaptic plasma membrane of skeletal muscle, allowing the influx of sodium ions 
(Na+) and the outflow of potassium ions (K+). This leads to miniature endplate potentials 
and greater depolarization of the muscle plasma membrane [1]. When the depolarization 
reaches a specific threshold, AP will be initiated. Propagation of the APs along the muscle 
membrane and through the T-tubules triggers the release of Ca2+ from the sarcoplasmic 
reticulum into the cytosol, leading to sarcomeric shortening as discussed previously. 
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1.4 NMJ-Related Diseases  
 NMJ formation and stabilization are tightly controlled via intricate molecular 
pathways. Mutation in the genes that participate in neurotransmission activities can lead to 
several neurodegenerative disorders that selectively affect motoneurons and skeletal 
muscle. Examples of NMJ-related diseases are spinal muscular atrophy (SMA), 
amyotrophic lateral sclerosis (ALS), hereditary spastic paraplegia (HSP), progressive 
bulbar palsy (PBP) and myasthenia gravis (MG). Common symptoms for patients with 
motoneuron diseases are compromised control of voluntary muscles of the body, muscle 
weakness and muscle wasting.  
In particular, SMA is an autosomal recessive neuromuscular disorder characterized 
by deterioration of lower motoneurons causing progressive muscle atrophy. The disease 
typically manifests early in life and it is the leading genetic cause of death in infants. 
Approximately 1 in 6,000 to 1 in 10,000 infants are affected with SMA, and about 1 in 40 
people are genetic carriers of the SMA gene [30]. In its acute form, SMA is fatal before the 
age of two [31]. SMA has historically been considered a pure motoneuron disorder and 
majority of researchers still believe that motoneurons play a critical role in the 
development of SMA. For example, a study showed that anti-smn1 miRNA expression in 
motoneurons, but not in muscle cells, was sufficient to cause SMA pathologic hallmarks, 
including defective motoneuron development, reduced motor function and early death [32]. 
Other studies have shown nerve and muscle specific events in SMA, including atrophy of 
muscle fibers and accumulation of neurofilaments at NMJ [33], loss of motoneuron cell 
bodies [34] and denervation of NMJ caused by loss of presynaptic inputs [35]. But there 
are emerging numbers of studies showing the potential role of muscle in the pathogenesis 
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of SMA. For instance, an experiment using coculture of rat motoneurons and human SMA 
myoblasts pointed to an active role of muscle in the degeneration [36]. Clearly, NMJ 
model provides myriad insight and useful information for SMA research and in vitro 
models can be used to further elucidate the potential roles of motoneurons and muscle in 
the progress of SMA. For instance, stem cell or iPSC techniques allow the derivation of 
skeletal muscle or motoneurons from diseased/healthy patients [37-42]. The coculture of 
diseased motoneurons with healthy muscle cells or vice versa allows the study of relative 
roles of each cell component on progression of SMA.   
Currently, there are many treatments under investigation to treat SMA. For 
instance, gene therapy focuses on SMN1 gene replacement to restore its function by 
inserting nucleotide sequence of SMN1 transgene into target motoneurons, which could 
potentially lead to increased production of SMN protein required to alleviate SMA 
progression [43, 44]. SMN2 alternative splicing modulation is also currently explored to 
increase the likelihood of full-length SMN protein synthesis from SMN2 gene, which 
normally only leads to short SMN protein [45]. In addition, some treatment targets muscle 
function restoration instead of motoneurons in hope to counter the effect of SMA such as 
fast skeletal muscle troponin activator (FSTA) to potentially slow the rate of calcium 
release from the regulatory troponin complex of fast skeletal muscle fibers and may 
improve muscle function and physical performance [38, 46, 47]. 
Currently, there is one approved treatment for SMA. Nusinersen is the first 
approved drug to treat patients with SMA and it was approved by the U.S. Food and Drug 
Administration in late December 2016 and by the European Medicines Agency in May 
2017 after initial clinical trials showing that nusinersen was safe, well tolerated and 
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effective. Nusinersen is an antisense oligonucleotide intended to treat SMA caused by 
chromosome 5q mutations which lead to deficiency in SMN protein synthesis [48]. It 
modulates alternate splicing of the SMN2 gene by selectively binding to mRNAs carrying 
information needed for SMN protein synthesis and has the potential to enhance the amount 
of functional SMN protein in infants and children with SMA [49-51]. Other neuromuscular 
disorders such as ALS and Duchene muscular dystrophy are also being extensively 
investigated [52-54]. With advancement in cell and molecular biology, gene therapy and 
increased awareness of the devastating neurodegenerative diseases, substantial resources 
has been put to the research of SMA and NMJ-related diseases, steering the development 
of the treatment, or even cure, in an encouraging direction.  
1.5 Current Effort and Applications of NMJ in vitro Models 
NMJ is widely used as a model to investigate synaptogenesis and 
pathophysiological development of neurodegenerative diseases [55-58] because of its 
relatively large size and accessibility compared to central synapses [11, 59]. The ability for 
dissociated primary muscle cells and motoneurons to generate functional neuromuscular 
transmission in vitro was first reported using chick cells in 1970 [60]. In such cultures, 
electrical stimulation led to action potentials recorded in the neuron which were followed 
by a brief depolarizing potential in the associated myotube membrane [61]. Early work on 
neuromuscular interaction in vitro focused on the chick and Xenopus model systems due to 
the ease and rapidity associated with using these cell. Studies utilizing rodent cells were 
later developed and seen as advantageous [62]. First, NMJ development in vivo has been 
studied in more detail in the rodent than in any other mammalian species and a greater 
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number of antibodies and gene expression probes are available for rodents than for avian or 
amphibian species. Moreover, established techniques for culturing rodent cells allowed for 
the development of cultures derived from transgenic or knock-out mice, even in cases 
where the mutation is lethal in late fetal development. Relatively recently, many research 
groups have created in vitro coculture systems using combinations of cell lines, primary 
cells, and stem cell-derived cells. For example, NMJ models were established in a serum-
free culture of rat primary cells [63], in a coculture of human stem cell-derived 
motoneurons and rat skeletal muscle [64], in a low-density coculture of mouse stem cell-
derived motoneurons and muscle cells [65], and in a coculture of motoneurons and 
myotubes generated from the same line of human induced pluripotent stem cells [66].  
NMJ in vitro models along with embryonic stem cell (ESC), induced pluripotent 
stem cell (iPSC) and direct reprogramming technology have provided effective approaches 
to study synaptogenesis and the underlying disease mechanisms. For instance, in vitro 
models generated from patient-specific tissues with genetic defects allow researchers to 
investigate the relative roles of muscle and motoneurons in neurodegenerative diseases [57, 
67-70]. Gene editing technique also provides the ability to repair underlying gene 
mutations in patient-specific cells, allowing the possibility of autologous cell 
transplantations [71, 72]. Therefore, in vitro models can significantly contribute to the 
analysis of the pathophysiology of neurodegenerative diseases, help screening for 




2 Objective  
The goal of the project is to develop a stable and functional model of NMJ to understand 
the synaptogenesis, regeneration, and maintenance of NMJ. Most of the current NMJ models 
[61, 62, 73, 74] are simply the coculture of muscle fibers and motoneurons. However, due to the 
complexity of the system and the motility properties of contracting muscle, the development of a 
practical NMJ model still remains a challenge. Further improvements are necessary to enhance 
the physiological relevance of the NMJ development system. An ideal NMJ model should 
provide a biomimetic niche for motoneurons and muscle cells, and enable precise control of the 
factors of interest such as the application patterns of electrical and mechanical stimuli. The 
model should also be simple, universal and easy to analyze.    
2.1 Hypothesis 
We hypothesized that the provision of a biomimetic environment guiding the organized 
growth of motoneurons and muscle cells will enhance functional coupling of the cells and enable 
quantitative studies of regulatory factors and underlying mechanisms of NMJ formation. 
Optimized coculture medium and electrical stimulation will support proper development of 
motoneurons, muscle fibers and NMJ formation.  
2.2 Specific Aims 
This dissertation aims to study extracellular signals as a modulator of NMJ development 
and function, with potential applications of the in vitro NMJ models as a therapeutic screening 
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platform and NMJ-related disease model. The biomimetic approach will be utilized to create a 
functional coculture system. Advantageous techniques in tissue engineering will be integrated to 
the model, including media optimization and electrical stimulation. Before the synergistic effects 
of these features can be investigated, their individual effects on muscle, motoneurons and NMJ 
should be well understood first. The study used mouse cells to create a relatively simple system.  
2.2.1 Optimize culture medium and protocol to support proper development of skeletal 
muscle, motoneurons and NMJ 
The cellular niche consists of the cell in coordination with the surrounding cells, the 
extracellular matrix, soluble factors, and biophysical signals [75]. Extracellular cues within this 
niche are incredibly important for promoting NMJ formation and stabilizing synaptic connection. 
Culture medium is a pivotal component for proper development of skeletal muscle, motoneurons 
and NMJ. Specifically, the culture medium must be able to support the growth of myocytes and 
maturation of motoneurons, induce multinucleated myotube formation, and enhance functional 
coupling of NMJ. We hypothesized that culture medium supplemented with growth factors and 
cytokines based on the distribution of their cognate receptors during muscle, motoneurons and 
NMJ development should lead to improved growth and functional coupling of NMJ. 
2.2.2 Determine the effects of electrical stimulation on skeletal muscle, motoneuron and 
neuromuscular junction formation 
The neuromuscular niche is an environment ideal for synaptic transmission and 
functional coupling contraction. Because muscle and motoneurons are both electrically excitable 
and the development is closely linked to their electrical activity, an integration of electrical 
stimulation to the coculture system of NMJ model should be advantageous. The goal is the 
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optimization of electrical stimulation parameters that can lead to proper cell development. The 
optimal electrical stimulation should attain a desired physiological response with minimal 
damage to the stimulated tissue and it should be designed to mimic the signal existing in nature 
under the conditions of interest, in this case, nerve signal. There are many variables in the 
electrical stimulation that can be regulated, for example, amplitude, frequency, stimulation 
duration, and waveform shape. Initiation and stimulation period also need to be considered.  
The efficiency of stimulation regime can be assessed by evaluating the following cell 
characteristics, including proliferation, maturation, differentiation, and functional integration of 
NMJ. Specifically, for C2C12, the effects of electrical stimulation on important synaptic proteins 
such as brain-derived neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF), 
Neurotrophin-3/4 (NT-3/4), ciliary neurotrophic factor (CNTF), and AChRs are examined. As 
for motoneurons, the study should focus on expression level of presynaptic factors, such as 
MuSK and agrin. The well-defined characterization of stimulation effect will provide improved 
options for directing and fine-tuning functional engineered NMJ model. 
2.2.3 Validate the functionality of in vitro models using pharmacological testing 
The ultimate objective of the research is to use the established NMJ model in real-world 
applications such as diagnostic platforms for drug screening, cytotoxicity study and investigation 
of the pathogenesis of neuromuscular disorders. For the dissertation, the validation and 
functionality of the established in vitro models will be demonstrated by using drugs that affect 
mechanisms involved in synaptic transmission. Pharmacological potency of each drug will be 
quantified by the drug-induced contraction frequency of the coculture. The goal is to show that 
this simple, yet effective, coculture system can be used for pharmacological screening and to 





II Optimization of Culture 
Protocols for Proper Development 




3 Effects of Different Culture Media on 
Mouse Myoblasts and Myotube Development 
3.1 Introduction 
 Myoblasts are primordial muscle cells with the potentiality of developing into myocytes 
and subsequently, myotubes. Cultured myoblasts retain a hypertrophic ability in vitro and are 
able to fuse, forming multinucleated myotubes capable of spontaneous contractile activity given 
the correct stimuli [76]. The formation of these multinuclear cells is fundamental to the in vitro 
study of skeletal muscle. Such cultures allow for investigation of the metabolic and functional 
activity of muscle fibers and muscle precursor cells without interference from other tissues as 
normally occurs in vivo. Skeletal muscle is heavily influenced by external stimuli and 
interactions with other cell types [77-79]. In vitro culture removes such external or systemic 
cues, therefor allowing a clearer investigation of the specific effect of chemical, physical and 
pathological challenges on the physiology and metabolism of skeletal muscle cells.  
 For the simplicity of in vitro models, an immortalized mouse myoblast cell line C2C12 
was chosen. C2C12 can capture the essential characteristics of skeletal muscle and has gained 
utility in the biomedical research for decades. The C2C12 cell line is a subclone of myoblasts 
established from normal adult C3H mouse leg muscle [80]. These cells are capable of rapid 
proliferation under high serum condition and they can later fuse to form multinucleated 
myotubes under low serum conditions or starvation, the precursors to contractile skeletal muscle 
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cells in the process of myogenesis [81]. Culture medium, hence, has significant effect on C2C12 
differentiation. Studies have shown that low level of serum or no serum at all can lead to 
improved differentiation and some has claimed that serum level has no effect on differentiation 
[82-85].  
The goal of the study is to determine the optimal culture medium that can effectively 
support the growth and differentiate C2C12 to myotubes. In addition, because C2C12 will later 
be cultured in the coculture medium (CM) in NMJ experiments, this study will compare the 
capacity of CM to other differentiation media in supporting proper development of C2C12. 
Three media will be examined: serum-free CM, differentiation medium (DM) and the 
combination of the two (Combined). The efficiency of the media will be assessed using the 
microscopic structure of muscle cells, cell viability in the culture, important gene expressions 
and protein levels, and functionality of myotubes derived from C2C12.  
3.2 Materials and Methods 
3.2.1 Cell Culture 
 
Figure 7 Experimental procedures: effects of different culture media on C2C12 differentiation 
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C2C12 was plated on a plastic tissue culture plate at the density of 250 cells/mm2. The 
number of cells in solution was calculated using a hemocytometer. 10 µL of the cell suspension 
was added to 10 µL 0.4% Trypan Blue solution (Sigma-Aldrich) to help distinguish between 
dead and living cells. 10 µL of the cell/ Trypan Blue solution was injected at each end of the 
hemocytometer to fill the 2 chambers by capillary action. Under a light microscope at 10X 
magnification, the number of cells present in each chamber was counted. Then the number was 
adjusted to obtain an estimation of the number of cells per mL, taken into accounting the dilution 
factor, squares counted and square volume. C2C12 was culture in growth medium (GM) for 2-3 
days until reaching about 80% confluent. Before changing to differentiation medium, cells were 
washed with phosphate buffered saline (PBS) (Thermo Fisher Scientific). There were three study 
groups using different media to differentiate C2C12 myoblasts into myotubes as shown in Table 
1. Cells were culture in differentiation media for 9 days. 








DMEM, high glucose DMEM, high glucose Advanced DMEM/F12  DMEM, high glucose 
12.5 mM HEPES 12.5 mM HEPES Neurobasal medium Advanced DMEM/F12  
10% FBS 2% horse serum 1% P/S Neurobasal Medium 
1% P/S 1% P/S 1X B-27 1% P/S 
  
1X ITS 1X GlutaMAX  2% horse serum 
20 ng/mL IGF-1 12.5 mM HEPES 1X ITS 
  
100 µM IBMX 1X B-27 
10 µM forskolin 1X GlutaMAX  
10 ng/mL BDNF  12.5 mM HEPES 
10 ng/mL GDNF 100 µM IBMX 
10 ng/mL CNTF 10 µM Forskolin 
20 ng/mL NT-3 20 ng/mL IGF-1 
20 ng/mL NT-4 10 ng/mL BDNF  
2 µg/mL laminin 10 ng/mL GDNF 
  10 ng/mL CNTF 
  20 ng/mL NT-3 
  20 ng/mL NT-4 
  2 µg/mL Laminin 
 
Table 1 Culture media for C2C12 differentiation 
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3.2.2 Cell Viability Test 
 Culture medium was aspirated and cells were washed with PBS to remove serum esterase 
activity generally present in serum-supplemented media. Serum esterase could cause an increase 
in extracellular fluorescence by hydrolyzing calcein AM. LIVE/DEAD™ Viability/Cytotoxicity 
Kit (Thermo Fisher Scientific) for mammalian cells was used. The assay solution was prepared 
by adding 20 uL of the supplied EthD-1 stock solution and 5 uL of the supplied calcein AM 
stock solution to 10 mL of sterile PBS. The resulting solution was vortexed to ensure thorough 
mixing and added to culture plates. Cells were incubated for 30-40 minutes at room temperature 
before analysis under florescence microscope.  
3.2.3 Immunostaining 
For acetylcholine receptor (AChR) staining, cells were incubated with 5 x 10-8 M of α-
bungarotoxin (Life Technologies) for 1.5 hours at 37 C prior to washing and fixing. Cells were 
then washed with PBS, fixed in PBS containing 4% paraformaldehyde (Sigma-Aldrich) for 15 
min, permeabilized using 0.1% Triton-X (Sigma-Aldrich) for 15 min, and blocked with 5% goat 
serum (Sigma-Aldrich) in PBS for 20 minutes. Cells were stained with primary antibodies for 2-
3 hours using monoclonal anti-α-actinin (sarcomeric) antibody (1:400, Sigma-Aldrich). After 3 
washes with PBS, cells were stained for one hour with the following secondary antibodies: goat 
anti-mouse Alexa Fluor 488 (1:500, Life Technologies), anti-GFP antibody (1:500, Abcam), 
Alexa Fluor 546 phalloidin (1:500, Life Technologies) for actin and 4',6-Diamidino-2-
Phenylindole (DAPI) (1:1000, Life Technologies) for nuclear staining. 
3.2.4 Quantitative Polymerase Chain Reaction 
Culture wells were aspirated, washed twice with PBS and treated with 500 µL TRIzol 
(Life Technologies). A scraper was used to scrape the surface of the well before transferring the 
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solution to an RNase-free 1.5 mL Eppendorf tube. Samples were treated with 100 µL chloroform 
(Sigma-Aldrich) and were shaken vigorously for 2 minutes. Following this, the samples were 
spun for 15 minutes at 4 C at a speed of 12,000 g. The upper aqueous phase from the resulting 
solution was transferred to fresh 1.5 mL Eppendorf tubes and treated with 250 µL isopropyl 
alcohol (Sigma-Aldrich). Then the samples were incubated at room temperature for 10 minutes 
before being spun for 10 minutes at 4 C at a speed of 12,000 g. The supernatant was removed 
and discarded. The samples were subsequently treated with 75% ethanol, incubated at room 
temperature for 5 minutes and spun for 5 minutes at 4 C at a speed of 10,000 g. The supernatant 
was then discarded and the samples left to dry for 15 minutes. The purified RNA was finally 
resuspended in 20 µL nuclease-free water. RNA yield and purity were quantified using a 
NanoDrop ND1000 spectrophotometer (Thermo Fisher Scientific).  
Gene Symbol Gene Name Assay ID 
Actn2 Alpha actinin Mm00473657_m1 
Agrn Agrin Mm01545840_m1 
Bdnf Brain derived neurotrophic factor Mm01334047_m1 
 Chrnb1 Nicotinic cholinergic receptor  Mm00680412_m1 
Gapdh Glyceraldehyde-3-phosphate dehydrogenase Mm99999915_g1 
Gdnf Glial derived neurotrophic factor Mm00599849_m1 
 Musk Muscle associated receptor tyrosine kinase Mm01346929_m1 
Myh15 Myosin heavy chain Mm01170207_m1 
Myog Myogenin Mm00446195_g1 
Ntf5  Neurotrophin 5 Mm01701591_m1 
Ntrk2 Neurotrophic tyrosine kinase type 2 Mm00435422_m1 
Syn2 Synapsin Mm00449780_m1 
TNNT3 Troponin Mm01268863_m1 
 
Table 2 TaqMan Gene Expression Assays 
A high capacity cDNA reverse transcription kit (Applied Biosystems) was used to reverse 
transcribe mRNA to cDNA. The following reaction mix was prepared: 2 µL 10x RT buffer, 0.8 
µL dNTPs (100 mM), 2 µL 10X RT random primers, 1 µL multiscribe reverse transcriptase (50 
 25 
U/µL) and 4.2 µL nuclease-free water. Each sample was prepared in an Eppendorf tube on ice 
and then transferred to a thermal cycler (Thermo Fisher Scientific). The samples were then 
incubated at 25 C for 10 minutes, 37 C for 120 minutes and then 85 C for 5 seconds. After this 
stage, samples could be stored at -80 C or continued to quantitative PCR analysis.  
Quantitative PCR was performed using the StepOnePlus Real-Time PCR system 
(Applied Biosystems). The PCR reaction mixture (12.5 µL TaqMan universal PCR Master Mix, 
2.5 µL cDNA, 1.25 µL probe and 8.75 µL nuclease-free water) was prepared for each gene to be 
analyzed in triplicate wells in a 96-well plate (Applied Biosystems). The plate was incubated at 
50 C for 2 minutes and 95 C for 10 minutes before being cycled 40 times at 95 C for 15 seconds 
and then 60 C for 60 seconds. The TaqMan Gene Expression Assays shown in Table 2 were used 
for detection of important muscular and motoneuron transcription factors. Gene expression 
values were normalized to GAPDH expression and presented as an expression relative to the 
control group by the 2-ΔCt method [86]. 
3.2.5 Western Blot 
 Culture medium was aspirated and cells were rinsed with PBS 3 times to collect protein 
samples. CelLytic M (Sigma-Aldrich) supplemented with protease and phosphatase inhibitor 
cocktails (Roche) was added to lyse cells and solubilize proteins. Culture plate was placed on a 
shaker for 15 minutes at about 100 RPM before the solution was transferred to an Eppendorf 
tube and centrifuged at 12,000g for 10 minutes at 4 C. The supernatant was collected and protein 
concentration was determined by Pierce BCA Protein Assay Kit (Thermo Fisher Scientific). 
Concentrated protein samples were diluted and 20 µL of the resulting solution was then mixed 
1:1 with a laemmli buffer stock solution (Sigma-Aldrich).  β-mercaptoethanol (Sigma-Aldrich) 
was also added to the laemmli buffer prior to mixing with the samples. The diluted samples were 
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incubated at 100 C for 5 minutes and 40 µL of each was then loaded into separate wells of Mini-
PROTEAN TGX Precast Gels (Bio-Rad Laboratories). 5 µL of Precision Plus Protein Western C 
standards (Bio-Rad Laboratories) was loaded into a single well in order to provide a reference 
marker for determining molecular weight of the separated proteins. Loaded gels were clamped 
into an electrode block and submerged in a running buffer consisting of 100 mL stock running 
buffer (Tris-Glycine-SDS) diluted in 900 mL dH2O. Electrodes were attached to the block and 
the samples subjected to a 120 V force for 75 minutes or until the samples had reached the 
bottom of the gel. Afterwards, the gel was removed from the apparatus and placed on top of a 
nitrocellulose membrane soaked in an ice cold transfer buffer consisting of 100 mL stock Tris-
Glycine transfer buffer (Bio-Rad Laboratories), 200 mL methanol and 700 mL dH2O. The gel 
and membrane were clamped into an electrode block positioned so that the nitrocellulose 
membrane was between the gel and the positive electrode to facilitate the transfer of negatively 
charged protein from the gel onto the membrane. The block was immersed in cold transfer buffer 
and subjected to a 100 V force for 120 minutes. After the run time, successful transfer of protein 
to the membrane was visualized and confirmed using Ponceau solution (Sigma-Aldrich). 
Presence of target proteins on the nitrocellulose membranes was confirmed through 
probing with specific antibodies for myogenin, tropomyosin, myosin heavy chain, actinin and 
GAPDH. Membranes were first washed 5 minutes 3 times in PBS to remove the Ponceau 
solution before being immersed in a blocking solution consisting of 0.1% TWEEN (Sigma-
Aldrich) and 5% milk fat protein (Premier International Foods) in PBS for 1 hour. The 
membranes were again washed 5 minutes 3 times with PBS and during this time primary 
antibodies were diluted in blocking solution (1:1000 dilution). The primary antibody solution 
was then added and the membrane incubated at 4 C overnight. Following this incubation step, 
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the membranes were washed 5 minutes 3 times in PBS while secondary antibody solutions were 
prepared. Secondary antibodies conjugated with alkaline phosphatase were diluted 1 in 1000 in 
blocking solution. The membranes were incubated with the secondary antibody solution for 2 
hours at room temperature and afterwards, washed 5 minutes 3 times. NBT/BCIP Substrate 
Solution (Thermo Fisher Scientific) was added to the membranes and produced purple-black 
precipitate, colocalized with the targeted protein bands. When the bands became easily visible, 
membranes were washed with water to stop the reaction and ready to be photographed.  
3.2.6 Statistical Analysis 
All experiments were repeated at least 3 times using cultures prepared on different days. 
Quantitative data were presented as mean ± standard deviation. qRT-PCR and western blot 
results were presented as a fold change relative to GAPDH. Statistical significance was evaluated 
with the one-way analysis of variance (ANOVA) with p = 0.05 (n = 5 biological replicates for 
qRT-PCR and n = 3 biological replicates for western blot). 
3.3 Results 
3.3.1 All groups of culture media can induce differentiation of myoblasts to form myotubes 
C2C12 cultured in GM proliferated well and reached 80-90% confluent within 2-3 days 
(Figure 8A). After 9 days of culture in differentiation media, all study groups can induce C2C12 
to fuse and form elongated, multinucleated myotubes as shown by brightfield images in Figure 
1B, but cell fusion was more ubiquitous in DM and Combined groups. Fluorescence images 
showed the colocalization of actin and α-actinin, which indicates the formation of sarcomere 





Figure 8 CM, DM and Combined media can differentiate C2C12 to form multinucleated myotubes 
(A) C2C12 cells were cultured in GM for 2-3 days until reaching 80-90% confluent. (B) After 9 days in 
differentiation media, C2C12 fused to form elongated multinuclear myotubes in all study groups. (C) Fluorescence 
images showed the colocalization of actin (red) and α-actinin (green) found in myotubes that were cultured in CM, 
DM and Combined media. (D) Fluorescence images showed the early AChR aggregation, a sign of muscle 
maturation, indicated by white arrows.  Scale bar: 100 µm. 
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more noticeable in DM and Combined groups (Figure 8C). Immunostaining of AChRs also 
revealed the early aggregation of the AChRs in myotubes cultured in DM and Combined media. 
3.3.2 Serum supplement supports the long-term culture of myotubes   
 After 9 days of culture in differentiation media, myotubes from different study groups 
were stained with LIVE/DEAD cytotoxicity kit. The extent of dead cells, indicated by red dye, 
was found to be more pronounced in the CM group, compared to the DM and Combined groups 
(Figure 9A). The results were more apparent when cell viability was assessed on myotubes that 
were cultured in differentiation media for 15 days (Figure 9B). Dead cells were commonly found 
in the culture using CM as a differentiation medium. The major difference between the CM and 
the other differentiation media is the lack of serum supplement. Therefore, the results support to 
the notion that serum supplement in differentiation medium is important for the long-term 
culture of myotubes.  
 
Figure 9 Serum supplement in differentiation medium supports the long-term culture of myotubes 
Fluorescence images of LIVE/DEAD stains showed cell viability of myotubes that were cultured in different 




Figure 10 Gene expression and protein levels of important muscular proteins found in myotubes cultured in 
different differentiation media  
(A) qRT-PCR analysis showed normalized expression levels of important muscular genes of myotubes found in 
CM, DM and Combined culture media. The expression levels of actinin and Tnnt3 found in the Combined group 
were significantly increased compared to those of the CM group. (B) Western blot showed increased muscular 
protein levels of the Combined group, compared to CM and DM groups. Specifically, the protein levels of 
myogenin, tropomyosin and actinin were significantly higher in the Combined group compared to those of the CM 
group. Quantitative data presented as mean ± SD. Statistical significance was evaluated with ANOVA (*p < 0.05, n 
= 5 biological replicates for qRT-PCR and n = 3 biological replicates for western blot). 
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3.3.3 Myotubes cultured in the Combined medium show an increase in important muscular 
gene expressions and protein levels 
 qRT-PCR showed that expression levels of muscular genes were generally higher in 
myotubes that were cultured in the Combined medium, compared to those cultured in the CM 
and DM media (Figure 10A). Particularly, the expression levels of α-actinin and troponin from 
myotubes cultured in the Combined medium were more than 3 times of the expression levels of 
myotubes cultured in the CM medium and the differences were also statistically significant. In 
addition, the results from western blots confirmed that myotubes cultured in the Combined 
medium expressed higher levels of muscular proteins compared to the other groups (Figure 10B). 
Specifically, the protein levels of myogenin, tropomyosin and α-actinin found in the combined 
group were significantly higher than those of the CM group. Therefore, based on the results from 
qRT-PCR and western blot, the Combined medium could be a superior differentiation medium 
compared to CM and DM.  
3.4 Discussion 
C2C12 is an immortalized myoblast cell line that can proliferate indefinitely and with 
proper condition, it can develop into a muscle fiber through myogenesis. The aim of the study 
was to determine the optimal culture medium that could effectively orchestrate terminal 
differentiation process of C2C12 myoblasts, during which the proliferating mononuclear 
myoblasts undergo cell cycle arrest and fuse together to form multinucleated myotubes. Three 
differentiation media were evaluated: CM, DM and Combined. CM is a serum-free medium 
normally used for motoneuron culture while DM is a horse serum-supplemented medium 
commonly used to differentiate myoblasts to myotubes. Combined medium is simply the 
combination of the two media with a few extra supplements (For detailed composition, see Table 
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1). The efficiency of differentiation media was assessed by evaluating the following cell 
characteristics, including structure, maturation, proliferation, differentiation and contractility.  
 Structurally, all differentiation media could induce C2C12 to fuse and form elongated, 
multinucleated myotubes as shown in Figure 8B. Immunostaining was performed to examine the 
existence and the localization of interested proteins in myotubes. α-actinin, a protein in the z line, 
and actin filaments were used to identify sarcomere structure, which indicates the maturity of 
myotubes. Myotubes from all the groups showed the colocalization of actin and α-actinin, 
suggesting the formation of sarcomere structure because α-actinin is an actin crosslinking protein 
involved in the attachment of the actin cytoskeletal framework to the plasma membrane [87]. 
The degree of fusion was also more pronounced in the DM and Combined groups. Moreover, 
myotubes cultured in the DM and Combined media showed an early aggregation of AChRs, 
signifying an initial sign of maturity.  
LIVE/DEAD stains revealed cell viability at the end of myotube culture. DM and 
Combined media could efficiently support the long-term culture of myotubes while CM medium 
led to significant cell death after 15 days of culture. One possible explanation was the lack of 
serum in the CM medium. Even though serum brought in the variability to the culture as the 
components were not defined, it contained high levels of nutrients and combination of growth 
factors. As a result, the capability to support a long-term culture was a justified trade-off for 
unaccountable inconsistency brought by the use of serum because coculture experiments would 
last longer than 9 days and it would provide more flexibility for the experiments.  
Other than morphological analysis and immunostaining, the maturity of myotubes was 
assessed by gene expression and protein level analysis. Results from qRT-PCR and western blots 
showed that myotubes cultured in the Combined medium exhibited generally higher gene 
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expressions and protein levels for important muscular proteins, especially α-actinin, myogenin, 
tropomyosin and troponin. In addition, spontaneous contraction was found in myotubes that were 
cultured in the DM and Combined media towards the end of the 9-day experiment. Contraction 
was more noticeable after 12 days in the differentiation media for all the groups, but it was 
relatively weak for myotubes cultured in the CM medium (Supplementary Video S1).    
 
 
Table 3 Summary table for effects of different differentiation media on myotube development 
In summary, Combined medium is the best differentiation medium out of the three media 
because it could effectively induce myotube differentiation, support long-term culture, enhance 
important muscular gene expressions and protein levels, and lead to stronger spontaneous 
contraction as summarized in Table 3. Therefore, low level of serum and additional supplements 





4 Effects of Electrical Stimulation on Skeletal 
Muscle Derived from Mouse Myoblasts 
4.1 Introduction 
Biomimetic niche is an extracellular environment that replicates the native milieu of 
tissues in the body. It consists of cells in coordination with the surrounding cells, the 
extracellular matrix, cytokines and biophysical signals [56]. Extracellular cues within this niche 
are incredibly important for promoting proper cell development. Because muscle is electrically 
excitable and the development is closely linked to the electrical activity, an integration of 
electrical stimulation to the culture system should be advantageous. Many studies have shown 
that electrical stimulation can accelerate sarcomere assembly [88, 89], promote appearance of 
myotubes, and subsequently produce spontaneously contracting muscle fibers [90-92]. 
Electrical stimulation needs to be applied such that a desired physiological response can 
be achieved with only minimal damage to the cells. During electrical stimulation, charge is 
carried by electrons in the electrode phase [93]. At the electrode/medium interface, charge is 
transferred and carried by ions in the culture medium. The ion movement determines the 
momentary presence of current in the medium and also the amount of electric stimulation that 
cells experience. To attain an appropriate electrical stimulation, many factors need to be 
considered. For example, electrodes must be biocompatible to avoid toxic or immune responses 
in the adjacent tissue or medium. They should also efficiently transfer charge from the electrode 
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material to the medium. Particularly, during charge transfer, nonreversible Faradaic reactions 
should be minimized because it is associated with electrode degradation and harmful byproducts. 
In many studies, carbon electrode is chosen due to its biocompatibility, high availability, superior 
charge injection characteristics, and high resistance to chemical reactions and corrosion [94-96].  
The goal is the optimization of electrical stimulation parameters that can lead to proper 
cell development. The optimal electrical stimulation should attain a desired physiological 
response with minimal damage to the stimulated tissue and it should be designed to mimic the 
signal existing in nature under the conditions of interest, in this case, nerve signal. There are 
many variables in the electrical stimulation that can be regulated, for example, amplitude, 
frequency, stimulation duration, and waveform shape. Initiation and stimulation period also need 
to be considered. 
To this end, C2C12 are electrically stimulated 6 hours per day with a frequency of 1 Hz 
and a pulse duration of 2 milliseconds, which is adequately long to excite skeletal muscle cells 
and also sufficient for the double layers on stimulation electrodes to dissipate between 
subsequent pulses [94]. Monophasic square-wave pulses are chosen due to the simplicity and 
compatibility with carbon rod electrodes [95]. Three stimulation voltages within the 
physiologically significant range of endogenous gradients of electrical fields will be examined: 3 
V/cm, 5 V/cm and 7 V/cm, with an unstimulated control. The efficiency of stimulation regime 
can be assessed by evaluating the following cell characteristics, including proliferation, 
maturation, differentiation, and contractile function. Specifically, the effects of electrical 
stimulation on important muscular proteins such as actinin, GDNF, NT 5, MuSK, Myogenin, 
troponin and AChRs are examined. The well-defined characterization of stimulation effect will 
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provide improved options for directing and fine-tuning skeletal muscle development and 
function. 
4.2 Materials and Methods 
 
Figure 11 Experiment timeline and an electrical stimulation bioreactor culture plate 
4.2.1 Bioreactor Culture with Electrical Stimulation 
Polydimethylsiloxane (PDMS) (Dow Corning) was used to fabricate bioreactor cassettes. 
Each bioreactor cassette had 5 rows of 6 wells, 1 cm x 1 cm in size. Carbon rods of 0.120 inch in 








same stimulation. The bioreactor was sealed to a 10 cm x 15 cm glass (Thermo Fisher Scientific) 
using PDMS. Before seeding cells, stimulation plates were coated with poly-L-ornithine 
(Thermo Fisher Scientific) and laminin (Thermo Fisher Scientific). Poly-L-ornithine solution 
was added to cover the whole culture surface and the plates were incubated for 2 hours or 
overnight at room temperature. The plats were rinsed with sterile water before adding the diluted 
laminin solution (20 µg/mL with sterile PBS) and incubating 2 hours or overnight at room 
temperature. Before use, laminin solution was aspirated and the plates were washed with PBS. 
C2C12 was plated in the bioreactor culture plate at the density of 250 cells/mm2 and was 
cultured in GM for 2 days until reaching about 80%-90% confluent. Cells were washed with PBS 
before changing to differentiation medium, Bare Minimum medium (BM) in this case. BM 
medium was composed of high glucose DMEM (Thermo Fisher Scientific), 2% house serum 
(Thermo Fisher Scientific) and 1% penicillin-streptomycin (Thermo Fisher Scientific). After a 
day of pre-culture in BM, electrical stimulation was initiated. Carbon rods of bioreactors were 
connected to leads from an S88X Dual Output Square Pulse Stimulator (Grass Technologies) 
generating continuous pulses at 1 Hz and 2 millisecond duration. Three voltages were evaluated: 
3 V, 5 V and 7 V, with an unstimulated control, and cells were stimulated 6 hours per day for 8 
days before samples were collected for analysis. For an additional control group, cells received 
electrical stimulation but 0.5 µM of tetrodotoxin (TTX) was added to the culture medium. We 
provided more description on bioreactor cleaning steps: After each experiment, the bioreactor 
cassettes were thoroughly cleaned. Specifically, to avoid protein accumulation on the carbon 
electrodes, the bioreactor culture surface and electrodes were scrubbed with a soft brush and then 
washed with a water jet. Afterwards, the plates were soaked in 70% ethanol for 1-2 hours, dried 
in the hood and autoclaved.   
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4.2.2 Calcium Imaging 
Myotubes were assessed for response to electrical stimulation using calcium imaging. 
Cells were stained with 5 µg/mL Fluo-4 AM (Thermo Fisher Scientific) diluted in pre-warmed 
Tyrodes Solution (Sigma-Aldrich) for 30 minutes and washed twice with Tyrodes solution prior 
to imaging. Cells were electrically stimulated every 10 seconds by 2 stimuli of 2 millisecond 
duration and a gap of 300 milliseconds between the two stimuli. A concentric electrode (FHC, 
Inc) was positioned about 100 µm away from an area on interest, and the amplitude of the 
electrical signal was set to 0.5 V. Concentration of TTX was 0.5 µM. Videos were taken on the 
Olympus IX81 using the Pike camera at 100 frames per second via the SPLASSH software [78]. 
Videos were imported into a MATLAB R2016b software that allowed users to measure average 
fluorescence intensity in an area of interest for each frame, yielding calcium intensity over time. 
4.2.3 Statistical Analysis 
All experiments were repeated at least 3 times using cultures prepared on different days. 
Quantitative data were presented as mean ± standard deviation. LIVE/DEAD images were 
quantified using ImageJ and Prism 7. RT-PCR results were presented as a fold change relative to 
GAPDH. Statistical significance was evaluated with the ANOVA with p = 0.05 (n = 6 biological 
replicates for qRT-PCR and n = 6 biological replicates for LIVE/DEAD). 
4.3 Results 
4.3.1 Optimal electrical stimulation gradients do not cause significant cell death in 
bioreactor culture 
 After 8 days of electrical stimulation in bioreactor culture, myotubes experiencing 
different stimulation voltages were evaluated for cell viability (Figure 12). Optimal electrical 
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stimulation should not inflict too much damage on cells and thus, minimize cell death. Electric 
field strength of 5 V/cm and 7 V/cm led to substantial cell death as shown by red dye in figure 
12A. Quantitatively, fraction of live cells dropped from 0.93 in control group to 0.62 and 0.36 in 
5 V and 7 V stimulation groups, respectively. On the other hand, electric field stimulation of 3 
V/cm did not cause significant cell death as the fraction of live cells was only reduced to 0.86 as 
demonstrated in Figure 12B. 3 V/cm was, thereby, chosen for the future stimulation experiments.  
 
Figure 12 Myotube viability after bioreactor electrical stimulation using different voltages 
(A) Fluorescence images of LIVE/DEAD stains showed cell viability of myotubes that were electrically stimulated 
at different voltages for 8 days, 6 hours per day. Scale bar: 100 µm. (B) Fraction of live cells after 8 days of 
electrical stimulation in bioreactor culture. Quantitative data presented as mean ± SD. Statistical significance was 
evaluated with ANOVA (*p < 0.05, n = 6 biological replicates). 
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4.3.2 Electrical stimulation structurally matures myotubes 
 Myoblasts from both control and stimulation groups fused to form elongated, 
multinuclear myotubes with colocalization of actin and α-actinin. However, striated sarcomeres, 
indicators of skeletal muscle organization and maturation, were routinely found only in 
myotubes cultured with electric field stimulation of 3 V/cm, suggesting that proper electrical 
stimulation could benefit myotube development by accelerating striation formation.  
 
Figure 13 Electrical stimulation structurally matures myocytes as evidenced by striated sarcomeres 
Florescence images showed the morphology of myotubes in the control and stimulation groups. Striated sarcomeres 
indicating mature myocytes were commonly found in myotubes from stimulation group using electric field strength 
of 3 V/cm. Red, green and blue represent actin, actinin and DAPI, respectively. Scale bar: 100 µm. 
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Figure 14 Effects of electrical stimulation on skeletal myotubes 
(A) qRT-PCR analysis showed normalized expression levels of important muscular genes of myotubes found in 
control, electrical stimulation with TTX in culture medium and electrical stimulation groups. (B) Calcium transients 
during electrical stimulation. The trace consisted of 3 X ~60 seconds recording spliced together. Two electrical 
stimuli of 0.2 seconds apart were delivered every 10 seconds. The first section was the control, second section was 
in the presence of TTX and the last section was after 5-minute wash. (C) LIVE/DEAD florescence images showed 
that cell death was minimal in all the study groups even if more dead cells were observed in Stimulation+TTX 
group. Scale bar: 100 µm. Quantitative data presented as mean ± SD. Statistical significance was evaluated with 
ANOVA (*p < 0.05, n = 6 biological replicates for qRT-PCR). 
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4.3.3 Electrical stimulation upregulates important skeletal muscular genes and TTX 
suppresses the response to electrical stimulation and abolishes the effect of electrical 
stimulation 
qRT-PCR results showed that expression levels of important skeletal muscular genes 
were generally upregulated in myotubes receiving electrical stimulation, compared to those 
found in myotubes receiving no stimulation and myotubes that received electrical stimulation, 
but TTX was added to the culture medium (Figure 14A). Particularly, α-actinin expression level 
of stimulated myotubes was almost 3 times of the expression level of myotubes receiving no 
stimulation. Moreover, the expression levels of AChR (Actn2), myogenin (Myog) and troponin 
(Tnnt3) were more than 3 times compared to those of unstimulated myotubes. Expression levels 
were also statistically significant when they were compared to those of control group and 
stimulation group with TTX, showing that TTX could abolish the effects of electrical stimulation 
on important skeletal muscular gene expression.  
Calcium imaging revealed calcium transients during electrical stimulation in different 
conditions (Figure 14B). Myotubes responded well to electrical stimulation as evidenced by 
calcium fluxes synchronizing with electrical stimulation. After adding TTX to the culture, 
calcium activities due to electrical stimulation were gradually blocked and they were completely 
suppressed after about 40 seconds. Following the washout of TTX and medium replacement, 
myotubes responded to electrical stimulation at the pre-TTX treatment level. The result indicated 
that TTX could suppress the response of myotubes to electrical stimulation. 
LIVE/DEAD fluorescence images compared viability of myotubes cultured in all the 
study groups (Figure 14C). Dead cells were not significant across all three conditions even 
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though more dead cells were found in the culture receiving electrical stimulation with TTX 
added to the culture medium. 
4.4 Discussion 
  The goal of the study was to investigate the effects of electrical stimulation on the 
development of myoblasts into myotubes. Electrical stimulation was introduced to the bioreactor 
culture because skeletal muscle is electrically excitable and its development is interconnected 
with electrical activities. It was hypothesized that the implementation of electrical stimulation 
would be beneficial for functional coupling of myotubes. The first objective was to determine the 
stimulation voltage that would not inflict major damage and lead to significant cell death. In this 
study, stimulation regime was monophasic square-wave pulse with the frequency of 1 Hz, 2-
millisecond duration and a relatively long time between pulses using carbon electrodes. 
Monophasic pulse was selected due to its simplicity. It also avoided the possible undesirable 
effect of biphasic pulse inhibiting signal propagation because the secondary hyperpolarizing 
pulse could interfere with the initiation of APs in motoneurons [97]. Moreover, carbon electrodes 
were chosen because they have high capacitance and high resistance to corrosion, resulting in 
better charge transfer characteristics and biocompatibility [95]. They were, consequently, 
nontoxic to cells as shown by Figure 12 that fraction of live cells was more than 90% when 
myotubes were cultured in the medium exposed to carbon electrodes. Importantly, muscle cells 
were maintained in the BM medium because the objective was to examine the effects of 
electrical stimulation on the development of myotubes, rather than the effects of enriched culture 
medium. Using the BM medium allowed the effects of electrical stimulation to be more 
discernible.  
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 The results in Figure 12 suggested that electric stimulation of 3 V/cm did not impose too 
much stress on myotubes and thereby, did not cause significant cell death. Electrical stimulation 
also supported myotube maturation as demonstrated by the early appearance of striated 
sarcomeres when compared to unstimulated myotubes. In addition to improved cellular 
structures, electrical stimulation led to upregulation of muscle-specific genes. Particularly, gene 
expression levels of α-actinin, AChRs (Actn2), myogenin (Myog) and troponin (Tnnt3) were 
significantly increased. We hypothesized that the benefits of electrical stimulation stemmed from 
an increase in calcium transients and contractions that enhanced activity-dependent development 
of skeletal muscle. Even though the stimulation regimen used in the study could not directly 
induce contraction, an increase in cell depolarization due to electrical stimulation could lead to 
more contractions. The increase in calcium activities and contractions could, therefore, 
contribute to the upregulation of important genes found in the studies. In addition, when TTX, a 
voltage-gated sodium channel antagonist, was applied to the coculture, induced calcium 
transients as a result of electrical stimulation and contraction activities were significantly 
suppressed. The reduction of spontaneous contraction activities and calcium transients by TTX 
can potentially explain why the benefits of electrical stimulation were abrogated. Moreover, 
studies showed that denervation of muscle from motoneurons leads to muscle atrophy as 
denervation deprives muscle from synaptic activities and physiological Ca2+ transients [98, 99]. 
These results, therefore, further substantiate our hypothesis that the observed advantageous 
changes found in myotubes were induced by electrical simulation and that electrical stimulation 
might affect myotube development via calcium signaling. 
TTX has been known to cause paralysis and inhibit muscle contraction via Na+ channel 
blockade [100]. TTX changes Na+ permeability normally associated with excitation, preventing 
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Na+ inflow and therefore, preventing depolarization and contraction. Notably, muscle at different 
stages respond to TTX differently, for instance, myoblasts are resistant to TTX while myotubes 
are more amenable [101]; the sensitivity of the muscle action potential changes from 10 µM to 
10-500 nM during development. In addition, it was shown that most spontaneous contractions of 
rat myotubes in culture were blocked by 100 nM TTX and that 1 µM TTX abolished contractile 
activity in both neural and aneural muscle cultures. This suggests that Na+ play a major role in 
the dihydropyridine receptor (DHPR) voltage sensor activation at the level of the T-tubules, and 
consequently the calcium release from the sarcoplasmic reticulum and the contraction [102]. As 
a result, the concentration of TTX used in the present study should be sufficient to suppress most 
of the spontaneous activities. To further confirm the validity of using TTX to suppress 
contraction and calcium activities, the study conducted by Lorenzon, et al. showed that 1 µM 
TTX could effectively block global calcium activities of C2C12 [103], which could be a 
potential mechanism underlying the benefits of electrical stimulation. Therefore, suppression of 
spontaneous contraction activities and calcium transients by TTX can potentially explain why the 
benefits of electrical stimulation such as an upregulation of important muscular genes were 
abolished when C2C12 were electrically stimulated in the culture medium supplemented with 
TTX. However, some calcium activities, including Ca2+ oscillations and localized Ca2+ spikes, 
can still be found even when using high concentration of TTX [103]. To avoid ambiguity and 
improve the current study design, calcium channel blockers could be used instead of TTX to 
clarify the underlying mechanism of electrical stimulation on muscle cells.  
In summary, the study suggested that proper electrical stimulation could benefit myotube 
development by improving skeletal muscle morphology, accelerating striation formation and 
enhancing important muscular gene expressions without imposing significant stress and damage 
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5 Transdifferentiation of Mouse Embryonic 
Fibroblasts to Myocytes and the Effects of 
Electrical Stimulation  
5.1 Introduction 
Transdifferentiation, also known as lineage reprogramming, is a procedure that 
transforms mature, fully differentiated somatic cells into other somatic cell types through the 
introduction of defined transcription factors without undergoing an intermediate pluripotent state 
[104]. The technique is a promising cellular and tissue generating approach because it 
circumvents important concerns from the use of ESCs and iPSCs. First, isolation and expansion 
of human ESCs from unfertilized oocytes of human volunteers can pose a significant challenge 
due to limited availability and therefore, lack of steady cell sources [105]. Although the use of 
iPSCs to derive a desired cell type may overcome the low availability and the dependency on 
volunteer donation found in ESC method, a limitation of induced pluripotency is the time it takes 
to reprogram the cells and then subsequently direct them to the preferred fate [106-108]. 
Moreover, the efficiency can be low because the protocols to generate iPSCs include a number of 
stages [109]. Importantly, both ESC and iPSC approaches possess elevated risks of teratoma 
formation [110]. 
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Transdifferentiation bypasses the pluripotent stage of ESCs and iPSCs. Studies have 
demonstrated that fibroblasts could be transdifferentiated to several lineages including 
cardiomyocytes [111, 112], hepatocytes [113], neurons [114] and skeletal muscle [115, 116] by 
ectopic expression of multiple lineage-specific transcription factors. Particularly, overexpression 
of myogenic differentiation factor (MyoD) has been shown to successfully convert many somatic 
cell types to skeletal muscle [90-92]. These transcription factors are introduced into cells via 
transfection or transduction. For this study, transduction using lentivirus, whose pathogenic and 
replicative properties have been removed to only keep the gene transport capability, is chosen as 
a gene transfer method. Compared to transfection, transduction is more versatile because the 
technique works in immortalized cells, primary cells and stem cells. In addition, its effect is 
dose-dependent and significantly less toxic to cells [117].  
The tetracycline inducible system is a powerful tool that allows temporal and dose-
dependent regulation of target transgene expression once lentiviral vector integrates its DNA into 
the host genome [118]. The transcription is reversible as it can be on/off in the presence of 
tetracycline or its derivatives such as doxycycline (Dox) [119]. Reverse tetracycline 
transactivator (rtTA-M2) is created by fusing tetracycline repressor (TetR) found in Escherichia 
coli bacteria with the VP16 activation domain of another protein found in the herpes simplex 
virus [120]. The resulting rtTA-M2 protein is capable of binding to DNA at specific tetracycline 
operator (TetO), placed upstream of a minimal promoter such as the CMV promoter, only if it is 
bound to tetracycline or one of its derivatives. Introduction of Dox to the system will, therefore, 
increase specific gene expression downstream of its promoter.  
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 In the current study, the efficiency of lentiviral transduction and tetracycline inducible 
system  to transdifferentiate MEFs into myocytes by overexpression of MyoD will be assessed 
via morphology, important gene expression levels and functionality. In addition, effects of 
electrical stimulation on transdifferentiation and myocyte development will be explored.  
5.2 Materials and Methods 
5.2.1 Lentivirus Production 
Human embryonic kidney cells 293 (HEK 293) were cultured in GM in T75 flask until 
reaching 90% confluency. Then 7 mL of high glucose DMEM medium supplemented with 10% 
FBS, 2-mercaptoethanol (Sigma-Aldrich), gentamycin (Thermo Fisher Scientific), sodium 
pyruvate (Thermo Fisher Scientific), MEM non-essential amino acids solution (Thermo Fisher 
Scientific) and glutamax (Thermo Fisher Scientific) was added to the culture 30 – 60 minutes 
before transfection. Separately, 9.5 µg of gene of interest, MyoD1 in this case, 3.3 µg of 
pMD2.G (Addgene) and 6.2 µg of psPAX2 (Addgene) were added to 625 µL of high glucose 
DMEM medium without supplements. 58.5 µL of calfectin (SignaGen Laboratories) was diluted 
in 625 µL of high glucose DMEM medium and the solution was added to the solution prepared 
earlier and incubated for 15 – 20 minutes at room temperature. Afterwards, the transfecting 
solution was added to the culture flask. After 5 hours of incubation, 13 mL of fresh medium was 
added. At 28th, 52nd and 76th hours from the start of transfection, 12 mL of culture medium was 
collected each time and 12 mL of fresh medium was added back. In total, 36 mL of medium was 
collected. To precipitate HEK and cell debris, the virus supernatant was centrifuged at 1000 rpm 
for 5 minutes at 4 C. Then the supernatant was filtered using 0.45 µm filter and added to Amicon 
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tube (50kDa) (Millipore). The tube was spun at 3400 rpm for 20 min at 4 C, making 50X viral 
concentration. The solution was homogenized by pipetting and was stored in -80 C freezer.  
5.2.2 Transdifferentiation of Skeletal Muscle from Mouse Embryonic Fibroblasts 
MEFs were initially cultured with high-glucose DMEM supplemented with 10% FBS 
until reaching 70% - 90% confluent. Lentiviral gene delivery system was used to stably 
transduce cells with rtTA-M2 and MyoD gene (about 10 MOI). To improve transduction, 
hexadimethrine bromide (Sigma-Aldrich) was added to the medium at a concentration of 8 
µg/mL. After transduction, Dox (Sigma-Aldrich) at a concentration of 3 µg/mL was added to the 
Combined differentiation medium. The culture medium was changed every two days and cells 
were cultured for 12 days before analysis. For electrical stimulation study, the stimulation was 
initiated one day after switching to the Combined medium with Dox. The stimulation regime was 
3 V/cm with the frequency of 1 Hz and the duration of  2 milliseconds for 6 hours per day. 
 
5.2.3 Statistical Analysis 
Quantitative data were presented as mean ± standard deviation. RT-PCR results were 
presented as a fold change relative to GAPDH. Statistical significance was evaluated with the 







5.3.1 MyoD overexpression via lentiviral transduction and tetracycline inducible system 
effectively transdifferentiates MEFs to functional myotubes 
MyoD is a key regulatory factor in skeletal muscle and its ectopic overexpression induces 
transdifferentiation of MEFs into myocytes [121, 122]. MEFs were transduced with a Tet 
operator/CMV promoter-MyoD lentiviral construct (TetO/CMV-MyoD) and a lentivirus 
containing rtTA-M2. The introduction of Dox into the culture activated rtTA-M2 to bind to TetO 
and initiate transcription of MyoD (Figure 15A).  
At the end of differentiation process, the morphology, protein and gene expressions levels 
of MEFs were compared to those of MEF-transdifferentiated myocytes. MEFs had round shape 
(Figure 15B) and stained positive for actin (Figure 15C), while MEF-transdifferentiated 
myocytes fused to form elongated and multinucleated myotubes (Figure 15D) that showed the 
colocalization of actin and α-actinin, indicating the formation of sarcomere structure (Figure 
15E). In addition, transdifferentiation led to significantly higher expression levels of important 
muscular genes, including α-actinin, MyoD and Myogenin (Figure 15F), suggesting the 
effectiveness of the tetracycline inducible system and transdifferentiation. Gene expression 
levels in reprogrammed myocytes were comparable to those of C2C12 mouse myoblasts, while 
the expression of the same genes in the control MEFs was barely detectable (Figure 15F).  
To demonstrate the functionality and maturity of MEF-transdifferentiated myocytes, 
muscle cells were electrically stimulated every 10 seconds using a concentric electrode with 2 
stimuli of 0.5 V, 2 millisecond duration and 300 milliseconds between the two stimuli, and 
calcium transients were recorded. The spikes of intracellular calcium flux in transdifferentiated 
myocytes assumed the frequency of electrical stimulation, indicating that myocytes derived from  
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Figure 15 Derivation and characterization of transdifferentiation of MEFs into skeletal myocytes. 
 (A) The diagram showing rtTA-M2 lentiviral construct and a lentiviral construct containing TetO/CMV-MyoD. A 
tetracycline inducible system via rtTA-M2 was activated by doxycycline and initiated MyoD transcription. 
Overexpression of MyoD induced transduction of MEFs into skeletal myocytes. (B), (C) Brightfield and 
fluorescence images of MEFs after 12 days in Combined medium. Actinin was not found in MEFs. (D), (E) 
Brightfield and fluorescence images of MEF-transdifferentiated myocytes showed multinucleated myotubes and the 
presence of actinin protein after 12 days in Combined differentiation medium. Red, green and blue represent actin, 
actinin and DAPI, respectively. Scale bar: 100 µm. (F) qRT-PCR analysis showed relative expressions of important 
muscular genes found in MEFs, transdifferentiated myocytes and C2C12 myoblasts. Expression levels of each gene 
were normalized by the expression levels found in MEFs. Quantitative data presented as mean ± SD. Statistical 
significance was evaluated with ANOVA (*p < 0.05, n = 5 biological replicates) (G) A diagram showing calcium 
transients of MEF-transdifferentiated myocytes being electrically stimulated every 10 seconds as shown by red 
arrows. Myocytes showed significant increase of fluorescence intensity corresponding to electrical stimulation.  
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MEFs were excitable and functional (Figure 15G, Supplementary Video S2). The myotubes 
formed from transdifferentiated myocytes also responded to chemical stimulation using nicotine 
(Supplementary Video S3). These results demonstrated that myocytes transdifferentiated from 
MEFs were structurally and functionally mature. Additionally, some myocytes and myotubes 
were found in the culture of transduced MEFs in the Combined medium that was not 
supplemented with Dox (Figure 16).  
 
Figure 16 Brightfield and fluorescence images of transduced MEFs and untreated MEFs 
Myocytes and myotubes were commonly found in the culture of transduced MEFs in Dox-supplemented Combined 
medium. Some myotubes were present in the culture of transduced MEFs using Combined medium without Dox. 
There was no myocytes in the control MEFs. Scale bar: 100 µm. 
 
5.3.2 Electrical stimulation upregulates the expression of muscular genes and improves the 
skeletal muscle morphology 
  Electrical stimulation upregulated important muscular genes in myotubes, including 
AChR, α-actinin, myogenin and troponin (Figure 17A). Expression levels of these genes were 
more than twice as high as in the unstimulated myotubes. Electrical stimulation also did not  
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Figure 17 Effects of electrical stimulation on transdifferentiated myotubes 
(A) qRT-PCR analysis presented elevated relative expressions of important muscular genes of stimulated myocytes 
compared to those of control group after 12 days in culture. The expression levels of AChR, actinin, myogenin and 
troponin found in stimulated myocytes were significantly increased compared to those of the control group. (B), (C) 
LIVE/DEAD stains of control and stimulated myotubes. (D), (E) Florescence images showed the morphology of 
myocytes in both groups. Striated sarcomeres indicating mature myocytes were commonly found in myotubes from 
stimulation group. Scale bar: 100 µm. Quantitative data presented as mean ± SD. Statistical significance was 
evaluated with the Student’s t-test (*p < 0.05, n = 5 biological replicates). 
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cause significant cell death in the culture as shown in Figure 17C compared to the unstimulated 
myotubes in Figure 17B. In addition, striated sarcomeres, indicators of skeletal muscle 
organization and maturation, were routinely found in myotubes formed from electrically 
stimulated myocytes after 10 days of culture (Figure 17E). Spontaneous contractions were 
observed by day 9 of culture for electrically stimulated myotubes, and only after more than 2 
weeks of culture for unstimulated myotubes (Supplementary Videos S4, S5). 
 
 
Figure 18 Striation found earlier in stimulation group compared to control group 
 (A) Striation (showed by white arrows) was commonly found in myotubes receiving electrical stimulation as early 
as day 10 in the culture. (B) Striation of myotubes in control group was observed at day 19. 
 
5.4 Discussion  
Transdifferentiation of MEFs into functional myocytes via a tetracycline inducible 
system proved to be an effective derivation process. Ectopic overexpression of MyoD was 
sufficient to push MEFs toward myogenic differentiation. Transdifferentiated myocytes could 
form multinucleated myotubes with colocalization of actin and α-actinin, indicating mature 
sarcomere structure (Figure 15E). The expression levels of important muscular genes were also 
comparable to those of myotubes formed from C2C12 mouse myoblasts (Figure 15F), suggesting 
high efficiency of transduction and tetracycline inducible system. A possible explanation for 
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slight discrepancy between gene expression levels of transdifferentiated myocytes and C2C12 
groups was that there were some undifferentiated MEFs after the transdifferentiation process. In 
addition to significant increase in muscular gene expressions, myotubes derived from MEFs 
were properly functional as they responded well to electrical stimulation and chemical 
stimulation using nicotine. Although Dox was not added to the culture of transduced MEFs, 
some cells still underwent transdifferentiation and converted to myocytes and myotubes (Figure 
16) because horse serum used in the Combined medium contained traces of Dox. Therefore, 
when using the tetracycline inducible system in cell culture, it is important to confirm that each 
batch of serum has no or low level of contaminating tetracycline that cannot interfere with 
inducible system. 
An advantage of transdifferentiation is that the technique not only allows autologous cell 
generation, but also bypasses the pluripotent ESC/iPSC stage, minimizing the risk of teratoma. 
The transdifferentiation process also takes shorter time compared to iPSC generation [123]. 
Moreover, the tetracycline inducible system has very tight control on expression, leading to low 
degree of leakiness. Nonetheless, this approach has some limitations. First, transdifferentiation 
has limited scalability because its lack of a proliferative precursor stage compromises the cell-
generating capacity of the system. To solve the shortcoming, fibroblasts were chosen as a cell 
source because they are abundantly available and easy to obtain. Another drawback of this 
approach was the introduction of viruses into cells. The mechanisms of Integrating viral vectors 
remain unclear and such usage could cause mutations when inserted into the genome. 
Transfection is an alternative approach, but transduction has been proven to be more effective 
and versatile as it works in immortalized cells, primary cells and stem cells. In addition, its effect 
is dose-dependent and significantly less toxic to cells. Regardless of a few downsides, 
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transdifferentiation offers a promising option for cell derivation in regenerative and personalized 
medicine applications. 
It was hypothesized that the application of electrical stimulation will be advantageous for 
functional coupling of myocytes to myotubes because myocytes is electrically excitable and the 
development is closely connected to their electrical activity. Studies have shown that electrical 
stimulation can accelerate sarcomere assembly [88, 89], promote appearance of myotubes, and 
subsequently produce spontaneously contracting muscle fibers [90-92]. The results in Figure 17 
proved that electrical stimulation led to a desired physiological response with minimal damage to 
the cells; 3 V/cm did not impose too much stress on myotubes and thereby, did not cause 
significant cell death. The stimulation also supported myotube maturation as demonstrated by the 
early appearance of striated sarcomeres when compared to unstimulated myotubes. In addition to 
improved cellular structures, electrical stimulation led to upregulation of muscle-specific genes. 
Particularly, gene expression levels of α-actinin, AChRs, myogenin and troponin were 
significantly increased. The results from transdifferentiated myocytes correspond with the results 
found in myotubes developing from C2C12. Notably, myotubes started to contract after 9 days of 
electrical stimulation, compared to up to 3 weeks for unstimulated cells [121]. Consistently, 
striations appeared sooner in stimulated myotubes than in the control group 10 days vs. 19 days, 
Figure 18).  
In summary, the study demonstrated that transdifferentiation is a viable approach to 
derive functional myocytes from MEFs. If offers an alternative method to obtain target cells with 
inherent advantages compared to ESC or iPSC approaches. Furthermore, electrical stimulation 
can support the development and transdifferentiation of myocytes by improving skeletal muscle 
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morphology, accelerating striation formation and enhancing important muscular gene 




6 Motoneuron Derivation and the Effects of 
Electrical Stimulation on Motoneuron 
Development  
6.1 Introduction 
Motoneuron, particularly lower motoneuron, is another main component in NMJ that 
propagates signals to transfer information from spinal cord to effector organs. Motoneurons are 
widely studied to investigate the development, synaptogenesis, coupling function and cell repair, 
both in monoculture and with other cell types such as muscle. Many research groups have 
studied cell interactions between motoneurons and muscle in in vitro NMJ models by utilizing 
primary motoneurons in the experiment. An advantage of using primary motoneurons is that the 
cell extraction process is relative simpler and required less time. However, disadvantages of 
using primary cell source are that cells had to go through harsh condition during enzymatic 
dissociation, which could cause major cell damage, and especially for motoneurons, 
heterogeneous mix of cells would likely be obtained from enzymatic separation. Stem cells are, 
therefore, preferable due to the superior characteristics, such as self-renewability and 
multipotency, making them an ideal candidate for in vitro models for disease study and drug 
screening. The ESC population is also far more reliable, originating from single clones instead of 
cells from the spinal cords of many litter mates. Moreover, the utilization of stem cells avoids the 
 60 
problem of tissue source limitation and facilitates sufficient cell supply for repetitive or large-
scale experiments. Importantly, stem cells allow genetic diversity in developing in vitro models 
as they can be genetically modified into specific disease models. 
 
Figure 19 Development and specification of motoneurons 
Adapted from Davis-Dusenbery, Brandi N., et al. Development, 2014. 141.3: p. 491-501. 
During gastrulation of early development, cell specification of the inner cell mass results 
in three germ layers such as ectoderm, endoderm and mesoderm. The dorsal region of the 
ectoderm is specified into the neuroectoderm via activin/bone morphogenetic protein (BMP) 
signaling inhibition and fibroblast growth factor (FGF) and Wnt signaling activation [124]. Then 
neural plate and neural folds are generated during neuralization process and they fuse to form 
 61 
neural tube. Rostral neural progenitors develop into motoneurons in response to caudalizing 
signals, from molecules such as retinoic acid (RA), followed by the ventralizing activity of Sonic 
hedgehog (Shh) [125]. Understanding this developmental pathway has allowed the development 
of a protocol to promote motoneuron differentiation from ESCs through timed exposure to RA 
and Shh. Cells differentiated in such a manner express the LIM homeodomain proteins Isl1, 
Lhx3 and Lim1, which are normally associated with spinal motoneurons, as well as the 
motoneuron specific homeobox transcription factor HB9, indicating the development of a 
specific spinal motoneuron phenotype from within this population [125]. As demonstrated 
earlier, mouse ESC-derived motoneurons express cholineacetyl transferase (ChAT) and vesicular 
acetylcholine transporter (VAChT), indicating that these cells are able to develop a cholinergic 
transmitter phenotype [125, 126]. These cells also display passive membrane potentials 
comparable to those of E18 rat phrenic motoneurons and their electrophysiological responses to 
the neurotransmitters GABA, glycine and glutamate are likewise characteristic of embryonic 
motoneurons[126].  
ESC-derived motoneurons can be purified and available in relatively vast quantities. A 
yield of 10 million motoneurons is not unusual using stem cell derivation technique while 
preparations from rat ventral horns usually yields just 2 to 3 million unsorted cells [9]. In this 
thesis work, magnetic-activated cell sorting (MACS) was chosen as a purifying method and it 
was performed using Miltenyi Biotec's MACS Technology, which used superparamagnetic 
nanoparticles (~ 100 nm) and columns. Motoneurons used in the study were differentiated from 
an ES cell line (HBG3) derived from a transgenic mouse line (mHB9-Gfp1b), in which enhanced 
green fluorescent protein (eGFP) and cluster of differentiation 2 (CD2) were expressed under the 
control of the mouse HB9 promoter. Antibody conjugated with magnetic nanoparticles was 
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designed to target CD2 on cell surface of derived motoneurons to capture them inside the 
column. The tagged cells were captured as the magnetic particle-cell complex passed through the 
column, which was placed between permanent magnets. Successful establishment and 
characterization of ESC-derived motoneurons of this culture model will allow smoother 
transition from animal model into developing human motoneuron-myotube cultures. This would 
greatly expand the use and relevance of this model for future research. 
Because motoneuron is electrically excitable and the development is closely linked to 
their electrical activity, an integration of electrical stimulation to the culture should be 
advantageous. Many studies have shown that electrical stimulation can benefit neural 
development by guiding axonal growth [127], improving synaptic connectivity [128], and 
enhancing neural regeneration and reinnervation [129]. The goal is the optimization of electrical 
stimulation parameters that can lead to proper motoneuron development. The optimal electrical 
stimulation should attain a desired physiological response with minimal damage to the stimulated 
tissue and it should be designed to mimic the signal existing in nature under the conditions of 
interest, in this case, nerve signal. There are many variables in the electrical stimulation that can 
be regulated, for example, amplitude, frequency, stimulation duration, and waveform shape. 
Initiation and stimulation period also need to be considered. The efficiency of stimulation regime 
can be assessed by evaluating expression level of presynaptic factors, such as neuregulin and 
agrin. The well-defined characterization of stimulation effect will provide improved options for 
directing and fine-tuning functional engineered NMJ model. 
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6.2 Materials and Methods 
6.2.1 Motoneuron Derivation 
 
Table 4 Medium compositions for motoneuron derivation 
Motoneurons used in the study were differentiated from an ES cell line (HBG3) derived 
from a transgenic mouse line (mHB9-Gfp1b), in which enhanced green fluorescent protein 
(eGFP) is expressed under the control of the mouse HB9 promoter. ES cell-derived motoneurons 
were obtained using methods described previously [125]. Briefly, HBG3 ES cells were grown on 
MEFs in ES cell medium. (Detailed compositions of each medium are provided in Table 4) After 
2 days, ES cell colonies were partially dissociated and cultured in DFK5 medium. Medium was 
replaced after 2 days and supplemented with 1 µM RA (Sigma-Aldrich), 300 nM Shh (R&D 
Systems), and 1 µM hedgehog agonist (R&D Systems). Embryoid bodies (EBs) were cultured 
for 4–5 days before being dissociated and sorted using magnetic-activated cell sorting by cluster 
of differentiation 2 (CD2), which was engineered to express under the HB9 promoter. Upon 
dissociation and wash with L15 medium, cell suspensions were incubated with 80 µL of L15 
medium and 10 µL of anti-rat CD2 antibody (Invitrogen; per 15 million dissociated cells) for 20 
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minutes at 4 °C. After washing again with L15 medium, cells were then incubated with anti-
mouse magnetic microbeads (Miltenyi Biotec) for 20 minutes at 4 °C. Finally, cells were passed 
through a magnetic column to separate CD2-GFP-positive cells from the other types. 
Subsequently, dissociated cells were seeded in 24-well plate double-coated with poly-L-ornithine 
(Sigma-Aldrich) and laminin (Sigma-Aldrich) at a density of 750 cells/mm2 and cultured in CM 
medium.  
6.2.2 Electrical Stimulation  
 
Figure 20 Stimulation plate for motoneuron culture  
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Stimulation plates were constructed from 12-well plate inserted with 4 pairs of carbon 
rods such that three wells in the same row received the same stimulation and carbon electrodes 
were spaced 1 cm apart for both bioreactors (Figure 20). Before plating cells, both stimulation 
plates were coated with poly-L-ornithine and laminin. After 2 days of pre-culture of 
motoneurons, carbon rods of bioreactors were connected to leads from an S88X Dual Output 
Square Pulse Stimulator (Grass Technologies) generating continuous pulses of 3 V, 1 Hz, and 2 
millisecond duration corresponding to a field strength of 3 V/cm. Motoneurons were stimulated 6 
hours per day for 6 days before samples were collected for analysis. The control groups in the 
bioreactors did not receive electrical stimulation. For additional study group, motoneurons 
received electrical stimulation, but 0.5 µM of TTX was added to the culture medium. 
6.2.3 Current Clamp for Action Potential Recording 
Motoneurons were seeded on glass coverslips double-coated with poly-L-ornithine and 
laminin. Astrocytes were also added to promote motoneuron survival and development. A few 
days after cell plating, motoneurons were identified based on GFP expression and action 
potentials recorded using conventional whole-cell current-clamp technique. Patch pipettes were 
fabricated from 1.5 mm outer diameter, 1.28 mm inner diameter filamented capillary glass 
(World Precision Instruments) with 2-5 MΩ resistance when filled with the pipette solution 
described below. Current protocol generation and data acquisition were performed using 
pClamp10 software and a Digidata 1550 digital to analog converter (Molecular Devices). Traces 
were filtered at 10 kHz using a low-pass Bessel filter, and digitized at 10 kHz. All recordings 
were performed at room temperature and are corrected for a calculated liquid junction potential 
of -14 mV. Internal solution contained the following: 130 mM potassium methanesulfonate, 10 
mM sodium methanesulfonate, 10 mM HEPES, 10 mM EGTA, 1 mM CaCl2, 5 mM MgATP, 
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and 0.3 mM NaGTP, and pH was adjusted to 7.4 using KOH. External solution was Ringer’s 
solution containing the following: 145 mM NaCl, 5 mM KCl, 10 mM HEPES, 2 mM glucose, 2 
mM CaCl2, 2 mM MgCl2. pH was adjusted to 7.4 using NaOH and osmolality adjusted to 325 
mOsm with sucrose.  
6.2.4 Statistical Analysis 
Quantitative data were presented as mean ± standard deviation. RT-PCR results were 
presented as a fold change relative to GAPDH. Statistical significance was evaluated with the 
ANOVA with p = 0.05 and n = 5 biological replicates. 
6.3 Results 
6.3.1 Functional motoneurons are successfully derived from mouse embryonic stem cells  
Motoneurons used in the study were derived from HBG3 ESC line through the 
differentiation pathway shown in Figure 21A. Because GFP and CD2 were genetically 
engineered to express under the control of the motoneuron specific promoter HB9, they allowed 
simple identification of motoneurons in the culture and the use of MACS to isolate the cells. The 
functional maturity of motoneurons was assessed by whole-cell current clamp in coculture with 
astrocytes (Figure 21B). Motoneurons were able to fire APs as early as on day 2 of the culture 
(Figure 21C), but these initial signals were weak and cells could not produce continuous trains of 
APs. By day 4, motoneurons could consistently generate a robust firing of APs, indicating 
mature functional development of motoneurons.  
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Figure 21 Derivation and characterization of motoneuron 
(A) Motoneurons were derived from ES cell line (HBG3) with GFP under HB9 promoter. Differentiation process 
started from neural induction of primitive ectoderm into rostral neural cells. RA subsequently induced caudal neural 
fate, followed by Shh signaling, converting cells to motoneurons. (B) Overlay of brightfield and fluorescence 
images of GFP+ motoneuron and astrocyte coculture during whole-cell current clamp experiment. Scale bar: 100 µm. 
(C) Representative traces of AP measurements of motoneurons after a few days in culture. Weak single AP was 
observed on day 2. A weak train of APs was observed on day 3 and motoneurons were functionally mature on day 4 
as evidenced by a robust firing of APs. Vertical scale bar: Vm = 10 mV, Im = 200 pA. Horizontal scale bar: 0.1 
seconds.  
 
6.3.2 Electrical stimulation escalates important neuronal gene expressions and its effect is 
abolished by the presence of tetrodotoxin in the culture  
After 6 days of electrical stimulation, expression of neuronal genes in stimulated 
motoneurons was compared to the control group receiving no stimulation and to the 
motoneurons receiving stimulation in the presence of tetrodotoxin (TTX) in culture medium. 
qRT-PCR showed significant increases in the levels of brain-derived neurotrophic factor 
(BDNF) and tropomyosin receptor kinase B (Ntrk2) genes in the stimulated group relative to the  
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Figure 22 Effects of electrical stimulation on motoneurons 
(A) qRT-PCR analysis showed normalized expression levels of important neuronal genes of motoneurons found in 
control, electrical stimulation with TTX in culture medium and electrical stimulation groups. (B) Calcium transients 
during electrical stimulation. The trace consisted of 3 x ~60 seconds recording spliced together. Two electrical 
stimuli of 0.2 seconds apart were delivered every 10 seconds. The first section was the control, second section was 
in the presence of TTX and the last section was after 5 minute wash. (C) LIVE/DEAD florescence images showed 
the viability and morphology of motoneurons in culture. Scale bar: 100 µm. Quantitative data presented as mean ± 
SD. Statistical significance was evaluated with the ANOVA (*p < 0.05, n = 5 biological replicates).  
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control group of motoneurons. The fold change expressions of those genes were more than twice 
as high as expressions measured for the control group (Figure 22A). The levels of synapsin, a 
gene involved in the regulation of neurotransmitter release and neuromuscular synapse 
maturation [130], also showed a trend of increase over levels measured for unstimulated neurons, 
but the difference was not statistically significant. The presence of TTX in the culture suppressed 
the effect of electrical stimulation on these genes.  
Calcium imaging revealed calcium transients during electrical stimulation in different 
conditions (Figure 22B). Motoneurons responded well to electrical stimulation as evidenced by 
calcium fluxes synchronizing with electrical stimulation. After adding TTX to the culture, 
calcium activities due to electrical stimulation were gradually blocked and they were completely 
suppressed after about 40 seconds. Following the washout of TTX and medium replacement, 
motoneurons responded to electrical stimulation at the pre-TTX treatment level. LIVE/DEAD 
fluorescence images showed viability of motoneurons cultured in different conditions (Figure 
22C). Even though more dead cells were found in the electrically stimulated motoneurons and 
those that were stimulated and cultured in TTX, the extent of dead cells was not substantial. 
Motoneurons from these groups showed comparable degrees of growth and axonal spreading. 
6.4 Discussion  
Motoneurons derived from HBG3 ESC line were genetically engineered to express GFP 
for easy cell tracking and CD2 to allow the use of MACS for cell purification. CD2, a surface 
antigen of the T-lymphocytes, was chosen because it is a well-described epitope that is 
immunologically tractable. CD2 is not trypsin sensitive, which is important since trypsin was 
used during dissociation of EBs. Moreover, CD2 is not expressed in neural cells [131], which 
were the target cells to purify. Importantly, cells expressing CD2 have not showed any detectable 
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phenotypes when compared to parental lines [132]. Under the conditions established in this 
study, motoneurons were functionally mature after only 4 days of culture, as indicated by robust 
firing of APs (Figure 20C). The conditions and duration of neural maturation were appropriate, 
because motoneurons would be mature by the middle of the coculture experiment, allowing 
sufficient time for functional coupling of skeletal muscle and motoneurons during NMJ 
formation.  
Because motoneurons are electrically excitable and the development is closely linked to 
their electrical activity, it was hypothesized that the implementation of electrical stimulation will 
be beneficial for functional coupling of motoneurons. We confirmed that electrical stimulation 
leads to upregulation of motoneuron-specific genes, such as Bdnf, Ntrk2 and Syn2. Adding TTX, 
a voltage-gated sodium channel antagonist, to the culture medium of motoneurons diminished 
calcium transients induced by electrical stimulation and abolished the effects of electrical 
stimulation on important neuronal gene expressions, confirming that the upregulation of neuronal 
genes was in fact triggered by electrical stimulation.  
In summary, the results demonstrated that motoneurons derived from ESC using MACS 
were structurally mature and functional within 4 days. This information helped with design and 
duration of the coculture experiment. Additionally, the electrical stimulation regime used to 
stimulate skeletal muscle was safe and beneficial to motoneuron culture and development, and 







III Establish a Stable and 
Functional Coculture Protocol and 
Characterization of In Vitro 
Neuromuscular Junction Models 
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7 Effects of Different Culture Media on 
Neuromuscular Junction Development  
7.1 Introduction 
NMJ model is a useful system that has facilitated researchers’ investigation on the 
development and cell-cell interactions of NMJ, specifically synaptogenesis, function, 
maintenance and remodeling. NMJ has been widely studied to elucidate homeostasis and 
pathology of not only peripheral, but also central nervous systems thanks to its large size and 
easy access. Currently, there are many in vitro NMJ models, but limited success has been 
achieved in developing a stable, well-characterized and functional in vitro system for NMJ. 
Many research groups have created in vitro coculture systems using combinations of cell lines, 
primary cells, and stem cell-derived neural and muscle cells. In particular, NMJ models were 
established in a serum-free culture of rat primary cells [63], coculture of human stem cell-
derived motoneurons and rat skeletal muscle [64], low-density coculture of mouse stem cell-
derived motoneurons and muscle cells [65], and coculture of motoneurons and myotubes 
generated from the same line of human induced pluripotent stem cells [66]. Because coculture 
medium must support both motoneurons and muscle cells in the coculture, proper medium 
should be able to maintain both cell types so they are healthy and able to develop into functional 
NMJs. Some of the criteria are: (1) myocytes must be maintained in a low level of serum to 
induce myotube formation and maintain long-term culture; (2) the culture medium must be 
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supplemented with necessary growth factors and cytokines to improve finicky MN survival; and 
(3) the medium should be able to support NMJ development and functional coupling between 
motoneurons and muscle. The efficiency of coculture media will be assessed by evaluating the 
following cell characteristics, including maturation, differentiation, and functional integration of 
NMJ. The well-defined coculture medium will offer significant improvement on functional 
engineered NMJ model. 
7.2 Materials and Methods 
7.2.1 Cell Culture for Coculture Medium Study 
 
 
Figure 23 Timeline for coculture medium experiment and the components of each coculture medium  
 74 
C2C12 was first seeded at 250 cells/mm2 in GM and cultured for 2 days. Then 
motoneurons were added to the coculture at 750 cells/mm2. Three coculture media, including 
CM, Combined and CMHS, were used in the experiment to assess their ability to sustain cell 
survival and support the growth and formation of NMJ. The culture was maintained for 8 days in 
each medium before sample collection for subsequent studies such as immunostaining, 
contraction study, PCR and western blot. The coculture medium was changed every other day. 
7.2.2 Statistical Analysis 
Gene expression levels and pharmacological potency were analyzed using GraphPad 
Prism 7. Results were represented as mean ± standard deviation. Statistical significance levels 
were set to p = 0.05. 
7.3 Results 
7.3.1 Proper medium supplements support better morphological development and function 
of neuromuscular junction  
Motoneurons and myocytes were cultured in the coculture media for 8 days and we found 
more myotube formation in the Combined and CMHS groups compared to the CM group. In 
addition, the colocalization of AChR clusterization and motoneurons and their axons were more 
distinct in the coculture that was maintained in CMHS medium. Noted that the moderate degree 
of clusterization was also observed in the Combined group. Importantly, muscle contraction was 
more widespread and stronger in the CMHS and Combined groups compared to the CM group 
(Supplementary Video S6). The contraction was observed as early as day 4, compared to day 7-9 




Figure 24 Morphology and immunostainings of the coculture in different coculture media 
7.3.2 Optimal medium composition upregulates important gene and protein expressions 
PCR results showed the expression levels of important muscular and neuronal genes 
found in cells cultured in different coculture media. Among the three coculture media, CMHS 
generally led to the significant upregulation of gene expression levels, including AChR, MuSK, 
Myogenin, NT5 and TNNT3, followed by Combined and CM. Noted, the expression levels 
found in CMHS groups are more than two folds of those found in CM. In addition, combined 
medium increased the expression of level of GDGF to more than 4 times of the expression of the 
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CM group, followed by the CMHS group. The results from western blot further supported the 
outcomes found in PCR. CMHS and Combined media led to the significantly higher protein 
expressions of MuSK, myogenin, tropomyosin and MHC, compared to CM medium. CMHS also 
upregulated the expression level of AChR, but the increase was not statistically significant. Over 
all, the results from PCR and western blot might suggest the favorable effects of CMHS and 
Combined media in the development of NMJ. 
 
Figure 25 Expression levels of important neuromuscular genes found in cells cultured in different medium 
 
Figure 26 Expression of important neuromuscular proteins found in cells cultured in different medium 
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7.4 Discussion  
 
Table 5 Summary table shows effects on different culture medium on the coculture 
Table 5 summarizes the results found in the experiment. CMHS seems to be the optimal 
coculture medium out of the three media because it could improve the morphology of NMJ as 
shown by the formation of myotubes and the colocalization of AChRs and the axons of 
motoneurons. CMHS also led to early and strong contraction of the coculture and importantly, 
resulted in the significant upregulation of important neuromuscular genes and proteins as 
demonstrated by the PCR and western blot. Therefore, this study provides an excellent basic 
protocol for the culture system of an in vitro NMJ model and CMHS will be used for the 
subsequent coculture experiments in this thesis. 
A potential explanation for the observed beneficial effects of CMHS might be attribute to 
the supplemented serum and other growth factors. Serum was added to the coculture medium to 
support myocyte differentiation into myotube and long-term culture. The coculture medium was 
also supplemented with many growth factors because motoneurons are notoriously difficult to 
maintain in vitro [9, 108]. Evidence suggests that motoneurons in vivo need to make contact with 
their target muscle fiber as well as with Schwann cells, glial cells and interneurons in order to 
receive the necessary positive signals to survive [109]. Conventional in vitro cultures obviously 
 78 
lack this complexity and as such, cultured motoneurons do not receive the necessary secreted 
factors to promote their survival. Therefore, culture medium heavily supplemented with growth 
factors and supplements based on the distribution of the cognate receptors during muscle 
development and neuromuscular junction formation is more likely to better support the proper 
development of NMJ. Moreover, we aimed to culture motoneurons for at least 6-7 days, allowing 
cells to be fully mature and able to function based on the previous experiment on motoneuron 
monoculture where motoneurons could consistently fire APs in as early as 4 days, indicating its 
maturity and functionality. 
In addition, we tried to use two medium recipes for the coculture system, in which the 
first medium contained growth factors such as BDNF, GDNF, NT 3/4 and CNTF, and the second 
medium was similar to the first medium, but without growth factors. The rationale was that 
switching of media from enriched medium 1, which ensured the survival and growth of 
motoneurons and muscle cells, to medium 2 enabled the reciprocal induction between 
motoneurons and myotubes that naturally occurs in NMJ development [64]. Mature muscle cells 
should be able to secrete BDNF, GDNF, and NT 3/4 to support motoneuron survival and attract 
neurite outgrowth, as well as provide distinct signals to organize the formation, maturation, and 
maintenance of motor nerve terminals. Moreover, motor axons should secrete neuregulin and 
agrin to increase local AChR synthesis and aggregation, and ACh to stabilize and refine the 
synapses. However, the two medium recipes for the coculture system could not sustain survival 
and growth of myotube and motoneurons, unlike CMHS medium. A possible explanation might 





8 Characterization of In Vitro 
Neuromuscular Junction Models and an 
Application in Pharmacological Study 
8.1 Introduction 
In vitro NMJ model is a powerful cell biology tool to study NMJ formation and the role 
of different growth factors, hormones and cellular structures involving in synaptogenesis. The 
creation of a validated model will provide not only myriad insight about formation, regeneration, 
and maintenance of NMJ, but also useful information of synaptogenesis in general, allowing the 
NMJ to serve as a model for smaller and less-accessible central synapses. In this study, the 
established in vitro NMJ models will be validated by assessing their responses to therapeutic 
agents known to affect particular mechanisms during neurotransmission. 
During synaptic transmission, a transferase enzyme, choline acetyltransferase (ChAT) 
synthesizes ACh from acetyl CoA and choline, which is brought into the cytoplasm from the 
synaptic cleft and extracellular space via choline transporter. ACh is packaged into 
neurotransmitter vesicles by ACh transporter. Neurotransmitters are situated in the readily 
releasable pools of vesicles near the presynaptic terminal of motoneurons. During synaptic 
vesicle fusion, neurotransmitter vesicles from reserve pools are tethered to the membrane. Then 
the v-SNARE and t-SNARE proteins transiently associate in a calcium-independent manner to  
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Figure 27 Mechanisms involved during neurotransmission 
dock the vesicles, which are later primed and complexins stabilize the primed SNARE-complex, 
rendering the vesicles ready for rapid exocytosis. When the membrane at the synapse is 
depolarized by an AP, voltage-gated calcium channels around active zones will open, allowing 
an influx of Ca2+ down its electrochemical gradient. Ca2+ binds to synaptotagmin 1, dislodging 
complexin protein and allows the vesicle to fuse with the presynaptic membrane to release ACh 
neurotransmitter. ACh then diffuses across synaptic cleft to bind to nicotinic AChRs, ligand-
gated ion channels, on the postsynaptic muscular membrane. When ACh binds to AChR, it 
induces a conformational structural change, which forces the pore open, allowing for the flow of 
positive ions (Na+, K+ and Ca2+) down their respective concentration gradients in a non-specific  
© Brooks/Cole – Thomson Learning 
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Figure 28 SNARE and other molecular proteins during neurotransmitter vesicle release 
Adapted from Lodish, Harvey, et al. Molecular cell biology. 3. New York: Scientific American Books, 1995. 
manner. This eventually triggers APs as well as contraction in the muscle. The effect of ACh in 
the cleft is terminated by an enzymatic hydrolysis via acetylcholinesterase (AChE), reverting the 
receptor to its resting state, blocking further ion flow. Choline is later recycled back to the 
motoneuron’s axon terminal for ACh synthesis. 
In the experiment, five therapeutic agents were used to validate the established in vitro 
NMJ models. These drugs target different pathways during neurotransmission and they are 
useful in validating the function as well as the sensitivity of the established models. These agents 
include: 
1. Acetylethylcholine mustard hydrochloride, a precursor for ethylcholine mustard aziridinium 
ion, inhibits the synthesis of ACh by irreversibly inhibiting ChAT. In case of NMJ, the 
upstream blockade leads to the inhibition of neurotransmission and motoneuron’s inability to 
induce muscle contraction.   
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Figure 29 Neurotransmission mechanism targeted by different drugs 
2. Vesamicol is an experimental drug, which is categorized as a cholinergic physiological 
antagonist since it decreased the activity of cholinergic neurons. The drug reversibly blocks 
the intracellular vesicular acetylcholine transporter (ChAT) responsible for transporting ACh 
into neurotransmitter vesicles in the axon terminal of motoneurons. Inhibiting ACh loading 
results in empty vesicles fusing with motoneuron presynaptic membranes, leading to reduced 
release of ACh into the synaptic cleft. 
3. Botulinum toxin A (BoT-A) is a neurotoxin produced by Clostridium botulinum and it is one 
of the most lethal toxins on earth. The active form of the toxin protein composed of a heavy 







[133]. BoT-A enters an axon terminal and vesicles of motoneurons by binding to the 
presynaptic nerve terminal using its heavy chain As the vesicle moves farther into the cell, 
the light chain is activated, pushing itself across the vesicle membrane into the cytoplasm to 
cleave SNAP-25, a member of the SNARE protein family, which is responsible for fusion, 
preventing the cell from releasing vesicles of neurotransmitter and thus, stopping 
neuromuscular transmission [134]. The effect of BoT-A will be gradually reversed as the 
toxin loses activity and the affected motoneurons slowly regenerate the SNARE proteins. 
4. Pancuronium, an aminosteroid muscle relaxant, is a non-depolarizing curare-mimetic agent 
that blocks neurotransmission by competitively and reversibly binding to the nicotinic 
AChRs at the NMJ to inhibit the receptor activation by ACh.  
5. Neostigmine is a medication used to improve muscle function in patients with myasthenia 
gravis and to reverse the effects of non-depolarizing muscle relaxants at the end of an 
operation. Neostigmine increases neuromuscular activities by binding to the anionic and 
esteric sites of AChE and therefore, inhibiting the breakdown of acetylcholine in the synaptic 
cleft. More ACh can bind to the postsynaptic receptors and the depolarizing effect will also 
last longer.  
If the NMJ models respond to the drugs in a dose-dependent manner, the potency such as 
half maximal inhibitory concentration (IC50) and half maximal effective concentration (EC50) can 
be evaluated and compared to the values in the literature to further validate and improve the 
usefulness and physiological relevance of the in vitro models. This study is the first to validate 
the in vitro models using therapeutic agents that affect neuromuscular transmission. Two models 
will be evaluated: skeletal muscle derived from C2C12 mouse myoblasts and ESC-derived 
motoneurons, and skeletal muscle transdifferentiated from MEFs and ESC-derived motoneurons. 
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We hypothesize that the established model can capture the important characteristics of NMJ and 
will respond to the neuromuscular drugs in the expected and dose-dependent manners. If 
successful, we will be the first group to demonstrate a potential application of the in vitro NMJ 
models in drug potency study.  
8.2 Materials and Methods 
8.2.1 Cell Culture 
 
Figure 30 Timeline for coculture of ESC-derived motoneurons and MEF-derived myocytes 
Reprogrammed myocytes from MEFs were obtained as described previously with slight 
modification. 2 days after transduction, cells cultured in differentiation media supplemented with 
Dox were electrically stimulated with continuous pulses of 3 V, 1 Hz and 2 ms duration for 3 
days, 6 hours per day. After 3 days, motoneurons were added to the culture and cells were 
cultured in the CMHS coculture media supplement with Dox for 1 day before initiating another 
electrical stimulation. The coculture was stimulated with the same stimulation regime 6 hours per 
day for 6 days before analysis.  
8.2.2 Glutamate-Induced Contraction  
 
Figure 31 Timeline for glutamate-induced contraction experiment 
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Glutamic acid (Sigma-Aldrich) was prepared by dissolving in water with the help of 
vortexing. The pH was later adjusted to 7.4 to be compatible with cell culture. Contraction of the 
coculture was stimulated by adding glutamate solution with final concentration of 0.75 mM and 
was usually visible after a few minutes. 
8.2.3 Pharmacological Potency Testing 
 
Figure 32 Timeline for drug potency testing experiment 
Pharmacological testing was performed at the end of the coculture. Drugs used in the 
study were prepared as stock drug solutions in water or 100% dimethylsulphoxide (DMSO) and 
sonicated if necessary to dissolve the sample. For the assays, the stock solutions were further 
diluted to the appropriate concentration using coculture medium. The DMSO concentration in 
the culture wells with the highest drug concentration did not exceed 1% to avoid cytotoxicity. 
Coculture was exposed to neostigmine (Sigma-Aldrich) and pancuronium (Sigma-Aldrich) for 
10 minutes and to acetylethylcholine mustard hydrochloride (Sigma-Aldrich), BoT-A (List 
Biological Laboratories) and vesamicol (Sigma-Aldrich) for 12 hours before being stimulated by 
glutamate (Sigma-Aldrich) with final concentration of 0.75 mM. After 5 minutes, coculture 
activities were recorded for contraction analysis.  
8.2.4 Contraction Frequency Measurement 
Contraction in coculture was recorded after drug exposure on the Olympus IX81 using 
the Pike camera at 75 frames per second via the SPLASSH software. The duration of a single 
recording was 30 seconds. At the beginning of each recording session, contrast and brightness of 
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the video image were optimized and the heated stage was kept at 37 °C during microscopic video 
recording. Videos were processed by a custom MATLAB software that correlated the changes of 
brightness between subsequent video frames in the region of interest with the frequency of 
muscle contractions [135]. 
8.2.5 Statistical Analysis 
Contraction frequency of the coculture was quantified using MATLAB R2016b. Gene 
expression levels and pharmacological potency were analyzed using GraphPad Prism 7. Results 
were represented as mean ± standard deviation. Statistical significance levels were set to p = 
0.05. 
8.3 Results 
8.3.1 Clusterization of AChRs in the vicinity of motoneurons and glutamate-induced 
contractions indicate the formation of functional NMJ 
After 8 days of coculture, motoneurons extended their axons to myotubes to make 
synaptic contacts with skeletal plasma membrane (Figure 33A). The muscle/motoneuron 
interactions resulted in the formation of NMJ and in muscle contractions (Supplementary Video 
S8). In addition, cells were immunolabeled to examine cellular and protein colocalization in the 
coculture. Myocytes were stained with α-actinin and α-bungarotoxin for actinin and AChRs, 
respectively. Motoneurons formed neuronal networks in coculture and AChRs aggregated near 
motoneurons, indicating maturation of AChR clusters and NMJ formation (Figure 33B). To 
prove that the contractions were caused by synaptic transmission, the cocultured cells were 
stimulated using glutamate. Muscle contractions were observed shortly after adding glutamate to 
the system, suggesting that functional NMJ was formed (Supplementary Video S9). Contraction 
 87 
 
Figure 33 NMJ formation and function. 
NMJ formation and function. (A) A screenshot from a contraction video (See Supplementary Video S8) showed the interaction between 
myotubes and axons of motoneurons via NMJ after 8 days of coculture. An asterisk indicated a location of NMJ formation between axons of 
motoneurons and plasma membrane of myotubes.  (B) Fluorescence image showed the localization of motoneurons and myotubes in coculture. 
Motoneurons formed a neuronal network and induced the clusterization of AChRs (showed by white arrows) in their vicinity, indicating properly 
developed myotubes and formation of NMJ. Red, green and magenta represent AChRs, motoneurons and actinin, respectively. Scale bar: 100 µm. 
(C) Normalized nicotine and glutamate-evoked calcium traces from calcium imaging on myotubes and motoneurons (See Supplementary Videos 
S9, S10). Nicotine could stimulate only myotubes while glutamate could trigger calcium flux only in motoneurons. Quantitative data presented as 
mean ± SD (n = 399 ROIs for myotubes and n = 105 ROIs for motoneurons). 
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of myotubes could only have resulted from neurotransmitter release at the NMJ due to 
motoneuron activation by glutamate. Glutamate could not directly stimulate myotubes as shown 
by calcium traces (Figure 33C), calcium transient recordings (Supplementary Videos S10, S11), 
and contraction videos (Supplementary Videos S12, S13). 
8.3.2 Induced contraction by glutamate yields less variability in contraction frequency 
The frequency distribution of spontaneous contraction and glutamate-induced contraction 
of the coculture were compared. Spontaneous contraction has an average contraction frequency 
of 0.56 Hz with standard deviation of 0.40 Hz while glutamate-induced contraction has an 
average contraction frequency of 1.15 Hz with the standard deviations of 0.25 Hz. It 
demonstrated that glutamate-induced contraction was less varied as shown in the following 
figure. The induced contraction showed a relatively normal distribution while the histogram of 
spontaneous contraction frequency was more dispersed. The results were even more noticeable 
when box and whisker plot was created. Induced contraction by glutamate is, therefore, 
preferable to spontaneous contraction as it is more controlled and should yield more reliable 
measurement for contraction frequency and in turn, lead to a more accurate evaluation for drug 
potency based on muscle contraction in later experiment. 
8.3.3 The NMJ model responded to drugs affecting neurotransmission in a dose-dependent 
manner 
To demonstrate utility of the NMJ model, the cocultures were used to study the potency 
of pharmacological agents involved in NMJ signal transmission and function. To this end, we 
examined all five interconnected mechanisms including ACh synthesis, ACh vesicular storage, 
ACh synaptic release, AChR activation, and ACh inactivation in the synaptic cleft (Figure 35A). 





Figure 34 Histogram and box and whisker plot of contraction frequencies of spontaneous and glutamate-
induced contraction 
for each drug, and contraction videos were recorded and analyzed. Dose–response curves 
exhibited concentration-dependent responses of NMJ to pharmacological agents. Specifically, 
acetylethylcholine mustard hydrochloride, a precursor for ethylcholine mustard aziridinium ion, 
blocked the synthesis of ACh and decreased the contraction frequency of the myotubes, with the 
half maximal inhibitory concentration (IC50) of 1.29 µM (Figure 35B). Vesamicol, a vesicular 
acetylcholine transporter (AChT) inhibitor, prevented filling of synaptic vesicles with ACh and 
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inhibited neuromuscular transmission, with IC50 of 113.60 nM (Figure 35C). BoT-A inhibited 
neurotransmission by preventing ACh release. BoT-A cleaved SNAP-25, a t-SNARE protein 
essential for neurotransmitter vesicle fusion with the plasma membrane of motoneuron terminals, 
with IC50 of 69.07 pM (Figure 35D). Pancuronium interfered with NMJ function by reversibly 
and competitively binding to AChRs and thereby reducing the contraction frequency of skeletal 
muscle, with IC50 of 10.71 µM (Figure 35E). Neostigmine enhanced neuromuscular activities by 
inhibiting acetylcholinesterase (AChE), a potent enzyme that catalyzed ACh, and terminated 
synaptic transmission, with the half maximal effective concentration (EC50) of 0.375 µM (Figure 
35F). Similar experiments were performed to assess the potency of these drugs using 
motoneurons derived from mouse ESCs and skeletal muscle transdifferentiated from MEFs. 
Acetylethylcholine mustard hydrochloride had an IC50 of 1.33 µM (Figure 36B), vesamicol had 
an IC50 of 98.08 nM (Figure 36C), BoT-A had an IC50 of 50.01 pM (Figure 36D), pancuronium 




Figure 35 Pharmacokinetic studies of various drugs affecting NMJ formed from motoneurons and C2C12.  
(A) A schematic shows the different cellular mechanisms involved in neuromuscular transmission. (B), (C), (D), (E), (F) Dose-
dependent responses of coculture contraction frequency exposed to different drugs. (B) Acetylethylcholine mustard 
hydrochloride blocked the synthesis of acetylcholine (ACh) by irreversibly inhibiting choline acetyltransferase (ChAT). A half 
maximal inhibitory concentration (IC50) was 1.29 µM. (C) Vesamicol inhibited vesicular acetylcholine transporter (AChT) and 
prevented filling of synaptic vesicles with ACh. Its IC50 was 113.6 nM. (D) Botulinum toxin A (BoT-A) prevented ACh release 
by cleaving SNAP-25, a t-SNARE protein essential for fusion of neurotransmitter vesicles with the plasma membrane of 
motoneuron terminals. Its IC50 was 69.07 pM. (E) Pancuronium blocked neurotransmission by reversibly and competitively 
binding to acetylcholine receptors (AChRs). Its IC50 was 10.71 µM. (F) Neostigmine increased neuromuscular activities by 
inhibiting acetylcholinesterase (AChE). Its half maximal effective concentration (EC50) was 0.357 µM. Quantitative data 
presented as mean ± SD, n = 6 biological replicates.   
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Figure 36 Potency studies of various drugs affecting NMJ formed from motoneurons and transdifferentiated myocytes.  
(A) A schematic shows the different cellular mechanisms involved in neuromuscular transmission. (B), (C), (D), (E), (F) Dose-
dependent responses of coculture contraction frequency exposed to different drugs. (B) Acetylethylcholine mustard 
hydrochloride blocked the synthesis of acetylcholine (ACh) by irreversibly inhibiting choline acetyltransferase (ChAT). A half 
maximal inhibitory concentration (IC50) was 1.22 µM. (C) Vesamicol inhibited vesicular acetylcholine transporter (AChT) and 
prevented filling of synaptic vesicles with ACh. Its IC50 was 98.08 nM. (D) Botulinum toxin A (BoT-A) prevented ACh release 
by cleaving SNAP-25, a t-SNARE protein essential for fusion of neurotransmitter vesicles with the plasma membrane of 
motoneuron terminals. Its IC50 was 50.01 pM. (E) Pancuronium blocked neurotransmission by reversibly and competitively 
binding to acetylcholine receptors (AChRs). Its IC50 was 0.501 µM. (F) Neostigmine increased neuromuscular activities by 
inhibiting acetylcholinesterase (AChE). Its half maximal effective concentration (EC50) was 0.461 µM. Quantitative data 
presented as mean ± SD, n = 6 biological replicates. 
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8.4 Discussion   
 
Table 6 A summary table comparing drug potencies deriving from two in vitro NMJ models 
This study is the first to create a functional in vitro NMJ model using ESC-derived 
motoneurons and myotubes derived from C2C12 and MEF-transdifferentiated myocytes to 
demonstrate the utility of the in vitro NMJ models in evaluating the pharmacological potency of 
drugs affecting neuromuscular synaptic communication. The coculture protocols are slightly 
different between the two models, for instance, sequences of media because we have to adjust 
the media regimen to facilitate the reprogramming of MEFs into myocytes for the skeletal 
muscle component of the NMJ model. Moreover, we believe that the unconverted fibroblasts did 
not substantially affect the development and the performance of the NMJ because we did not 
observe significant differences in the morphology, gene expressions and drug potencies between 
the two models. As shown previously, both cocultures could form functional NMJ models and 
effectively capture the functionality during synaptic transmission and the drug-induced response. 
Importantly, they exhibited a concentration-dependent response to the applied drugs and their 
potencies for each drug are comparable as shown in Table 6.  
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However, comparing the potency results from the NMJ models to the values found in 
literature was challenging because there is limited data of drug potency testing in in vitro NMJ 
models and the data obtained from other models still have sizeable ranges of potency values as 
shown in Table 7. The ranges are wide as these numbers were derived from different models 
using different cell sources, such as in vitro cell-based model models, in vivo models or human. 
In general, the results were within the cited ranges. Moreover, the model was very sensitive to 
drug concentrations as it could detect the concentration less than 1 nM in case of BoT-A. These 
encouraging results support the potential use of the established models in drug screening and 
cytotoxicity testing. 
Drug IC50 Values from Literature 
Acetylethylcholine mustard hydrochloride [136-138] 0.9 µM - 5.1 µM 
Vesamicol [139-141] 14.7 nM - 0.17 µM 
BoT-A [134, 142, 143] 25 pM - 2 nM 
Pancuronium [144-147] 5.5 nM - 5.62 µM 
Neostigmine [148-152] 0.23 nM - 10 µM 
 
Table 7 IC50 values of the drugs used in the study from literature search 
The excitation–contraction coupling mechanism in skeletal muscle begins with the 
propagation of an AP along the plasma membrane and the T-tubule system. Once 
dihydropyridine receptors (DHPRs) detect changes of membrane potential, they will interact 
with sarcoplasmic reticulum ryanodine receptors, causing release of Ca2+. Intracellular Ca2+ then 
binds to troponin, allowing actin-myosin interaction and muscle contraction. A spontaneous 
contraction is a property of the contractile system at low actin-myosin affinity. Even low Ca2+ or 
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changes in ionic strength can have effects on actin-myosin interactions [153]. Intrinsic 
contractions take place independent of synaptic activities. Its frequency and intensity are more 
diverse and are not under our manipulation; the distribution of contraction frequency is more 
dispersed when compared to induced contraction via glutamate stimulation. This is our 
underlying rationale for choosing the frequency of induced contraction instead of spontaneous 
contraction. According to the histograms and box and whisker plot showing distribution of 
contraction frequency in Figure 34, the deviation of induced contraction was less, leading to 
smaller variation of the measurement. A potential mechanism of intrinsic contraction involves 
the spontaneous activation of a T-type calcium current in the sub-threshold range of the 
membrane potential, which raises the membrane potential to the AP threshold and the release of 
Ca2+ stored in the sarcoplasmic reticulum [102]. It was shown that most spontaneous 
contractions of rat myotubes in culture were blocked by 100 nM TTX. This suggests that Na+ 
play an important role in the DHPR-mediated detection of changes in membrane potential at the 
level of the T-tubules [102]. Optogenetics can be utilized to study calcium transients during 
contraction and further investigate the mechanism of action [154]. On the other hand, electrically 
induced contraction occurs when electrical stimulation directly depolarizes the membrane of 
muscle cells and motoneurons, where increased voltages cause an activation of voltage-gated ion 
channels, leading to an influx of extracellular Na+/Ca2+ and allowing the membrane potential to 
reach the threshold easier. These activities can be blocked pharmacologically using Na+ or Ca2+ 
channel blockers. We did not directly measure the intensity or the force of contraction, but we 
hypothesize that the force induced by electrical stimulation should be higher as more muscle 
fibers could be depolarized by electrical stimulation, leading to increased activation of voltage-
gated ion channels, APs and contractions. For the dissertation, the emphasis is on the NMJ-
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driven contraction, which relies mostly on the synaptic activities and communication between 
motoneurons and muscle. Depolarization and APs in motoneurons causes the release of ACh 
neurotransmitter from axon terminals to the synaptic cleft, which later binds to AChRs on the 
skeletal plasma membrane, resulting in membrane depolarization and muscle contraction. The 
synaptic activities can be selectively isolated in the coculture experiment by various 
pharmacological interventions, including, inhibiting ACh synthesis, blocking ACh storage into 
neurotransmitter vesicles, preventing the release of ACh from the neurotransmitter vesicles into 
the synaptic cleft and inhibiting the binding of ACh to the AChRs on the postsynaptic muscle 
membrane. These interventions should not affect intrinsic activity of skeletal muscle and that is 
why we selected pharmacological agents that affect these pathway to evaluate the functionality 
of the NMJ in vitro models.     
 In summary, we established an in vitro NMJ model that incorporated electrical 
stimulation and performed systematic analysis to show the formation and function of the NMJ. 
The model provides a simple and robust method for analyzing pharmacological potency using 
drug-induced contraction frequency to quantify cell response to different concentration of 
applied drugs. The proposed NMJ model also offers application in therapeutic agent screening, 
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9 Perspectives  
9.1 Overall Conclusions 
NMJ is widely studied as a model to investigate synaptogenesis and 
pathophysiological development of neurodegenerative diseases [55-58]. To date, 
coculture methods established from various species have been described, including mouse 
[155-157], rat [158, 159] and heterologous cocultures derived from motoneurons and 
muscle cells of different species, such as rat-human [160], mouse-human [161] and 
mouse-chick [162]. These cocultures, however, resulted in the formation of immature 
myotubes and sarcomeric structures. Moreover, these models did not incorporate 
important factors intrinsic to the native physiological niche of NMJ, and the utility of the 
in vitro models of NMJ for investigating the pharmacological potency of drugs affecting 
synaptic communication has not been demonstrated.  
The goal of this thesis research is to create a stable and functional in vitro model of NMJ 
for physiologic and pharmacologic studies. To this end, we established a coculture protocol for 
NMJ formation from motoneurons and myocytes with the application of developmentally 
relevant electrical signals. We first determined the optimal culture medium that can support 
proper growth and development of both the muscle and motoneurons. Serum and supplemented 
growth factors, based on important cognate receptors during NMJ formation, were essential for 
development and long-term maintenance of NMJ. In addition, we evaluated the optimal electrical 
stimulation to further enhance the biomimicry and physiological relevance of the model while 
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ensured that the stimulation did not elicit detrimental effects on cell survival. Many studies have 
shown that electrical stimulation can promote muscle cell maturation, orientation, and 
differentiation leading to greater contraction of myotubes [92], and to benefit neural 
development by guiding axonal growth [127], improving synaptic connectivity [128], and 
enhancing neural regeneration and reinnervation [129]. An optimal electrical stimulation should 
attain a desirable physiological response with minimal damage to the stimulated tissue. The 
stimulating voltage of 3V was chosen because based on our study, 3V did not cause significant 
cell death compared to the control, unlike 5V and 7V, which led to substantial death of 
myocytes. In addition, a frequency of 1 Hz and a pulse duration of 2 milliseconds were utilized 
because they were adequately long to depolarize cells and also sufficient for the double layers on 
stimulation carbon electrodes to dissipate between subsequent pulses [94]. Monophasic square-
wave pulses were chosen due to the simplicity and compatibility with carbon rod electrodes [95]. 
Electrical stimulation was introduced to the muscle/motoneuron culture to mimic the native NMJ 
niche, where electrical signals are vital for NMJ development and function. We confirmed that 
electrical stimulation led to upregulation of motoneuron- and muscle-specific genes and 
improved cellular structures. A possible explanation for the beneficial effects of electrical 
stimulation is that the sub-threshold stimulation provided electrical activities that were absent in 
an in vitro culture environment, but needed in the activity-dependent development of 
motoneurons and myotubes.  We hypothesized that positive effects were attributed to increased 
calcium transients and contractions. Even though the stimulation regimen used in the study could 
not directly induce contraction, an increase in cell depolarization due to electrical stimulation 
could lead to more contractions. When TTX was added to the coculture, induced calcium 
transients as a result of electrical stimulation and contraction activities were significantly 
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suppressed. The reduction of spontaneous contraction activities and calcium transients by TTX 
can potentially explain why the benefits of electrical stimulation were abolished, further 
substantiating our hypothesis regarding activity-dependent benefits of electrical stimulation.  
This study is the first to create a functional in vitro NMJ model using ESC-derived 
motoneurons and MEF-transdifferentiated myocytes to demonstrate potential application of the 
NMJ model for testing potency of pharmacological agents that affect mechanisms involving in 
neuromuscular transmission. The coculture effectively captured the drug-induced response and 
functionality during signal transduction, and it exhibited a dose-dependent response to the 
applied drugs, allowing the evaluation of therapeutic potency, including IC50 and EC50. The 
model was also very sensitive to drug concentrations as it could detect the concentration less 
than 1 nM in case of BoT-A. The experiment is reproducible and could be used as a cytotoxicity 
platform in clinical applications. In conclusion, the optimized coculture medium implemented in 
conjunction with electrical stimulation resulted in a biomimetic model that effectively captured 
the critical characteristics and functions of the NMJ.  
9.2 Applications, Limitations and Future Work 
In vitro models will always have a place in drug screening and cytotoxicity testing 
because of the high throughput capability and simplicity. This is particularly true for 2D model 
even though 3D culture might be more biomimetic. For example, the established in vitro NMJ 
models offer an alternative method to test the median lethal dose (LD50) of BoT-A. Currently, 
the potency testing of some BoT-A products for therapeutic or cosmetic applications is based on 
an in vivo LD50 assay, which evaluates the amount of BoT-A needed to kill 50% of a group of 
mice that have been injected intraperitoneally [163]. For each batch of BoT-A, at least 100 mice 
are used to assess the LD50 level and the toxin causes diffuse muscular paralysis, impaired vision 
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and paralysis of the diaphragm, followed by suffocation and death of mice [164]. Manufacturers 
use the LD50 to grade the strength of their products and the in vivo method has frequently 
brought up controversies regarding ethical issues involving animal experiments. The criticism is 
even sterner as BoT-A is widely used for cosmetic procedures, instead of therapeutic 
applications. Currently, many countries ban the testing of cosmetic products and ingredients on 
animals, but since BoT-A is also used in therapeutic treatment, it is classified as medicine and 
can be tested on animals. In addition to the ethical concerns, there are other downfalls associated 
with the mouse LD50 assay as the bioassay is inherently variable and has a large intra/inter-
laboratory variability [165]. The mouse LD50 assay has also been found inadequate for 
evaluating differences in the potency of different manufacturer’s products, suggesting that the 
assay is inefficient at detecting some relevant factor [166]. Lastly, the mouse assay takes 1-4 
days to provide results, delaying production, diagnosis and detection applications that rely on 
this assay. Consequently, an alternative method to replace the in vivo mouse LD50 assay is in dire 
need for both the ethical concerns over the animal use and the scientific concerns over the 
inaccurate animal bioassay, especially now where there is growing demand and production of 
BoT-A products. A number of alternative in vivo, ex vivo, and in vitro methods for BoT-A 
potency testing have been in the development and some are validated as shown in the following 
table. We believe that our cell-based NMJ models can offer a simple and reliable platform to 
assess the LD50 level because the results showed reproducible dose-dependent responses of the 
models to BoT-A. Our models are also very sensitive as it can detect BoT-A at the concentration 
less than 1 nM. In addition, the use of stem cells allows large-scale experiments and minimizes 
genetic variation among assays, creating a unified standard for the LD50 testing. Therefore, we 
believe that the established in vitro models of NMJ can provide utility in cytotoxicity testing, 
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leading to a more systematic, accurate and humane assay for the potency and quality control tests 
used to produce BoT-A products. 
 
Table 8 Alternative methods to the in vivo mouse LD50 assay for BoT-A 
Adapted from Stephens, Martin L. Test Method Nomination to the ICCVAM, 2005. 
 
In vitro models can also play an important role in disease models, especially during an 
early stage of investigation because cell-based models allow the use of patient-derived cells, and 
the system is high throughput, well defined and tunable to answer different applications [167]. 
For example, a study conducted by Yoshida, et al. used SMA patient-derived iPSCs to create an 
in vitro model of NMJ to evaluate the efficacy of therapeutic candidate, valproic acid and 
antisense oligonucleotide, and investigate pathophysiological mechanisms of SMA [58]. The 
models could provide researchers with a fundamental understanding of disease development and 
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enable collection of potentially predictive data of experimental treatments before advancing to 
animal studies and clinical trials [52-54]. With more awareness of neuromuscular diseases, 
increase in resources dedicated to NMJ-related research and continuing progress in cell biology, 
genetics and regenerative medicine, ongoing effort to find effective treatments is heading in a 
promising direction.  
There are limitations found in the NMJ models created in the study. First, even though 
the current models could demonstrate dose-dependent responses to the applied drugs and allowed 
drug potency calculation, there are some flaws with the design of the experiments for 
pharmacological testing that could be practically addressed to improve the outcome of the study. 
For example, the induced contractions of the coculture were measured 5 minutes after adding 
glutamate and the limitation of this approach is that the characteristic activities due to the effect 
of the drugs might not be effectively captured as the activities might already become plateaued. 
To better assess neuromuscular activities, contraction should be measured right after glutamic 
stimulation. Better yet, additional data of calcium activities or electrophysiology would further 
provide comprehensive insight into the effects of the drugs. In addition, a more defined system 
can be created by applying optogenetic techniques [168-170]; motoneurons can be genetically 
engineered to express channelrhodopsin proteins, light-activated cation channels, which enable 
light to regulate depolarization, calcium transients and other cellular processes. To derive 
motoneurons with channelrhodopsin proteins, channelrhodopsin gene can be introduced into 
ESCs by gene delivery techniques, such as transduction and transfection. The ESCs will then be 
differentiated to motoneurons following the process described earlier in the study. An advantage 
of optogenetics is the ability to selectively activate motoneurons, resulting in cleaner results as 
glutamate, though not significant, can also affect muscular activities. The system can provide a 
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contactless and more defined way of investigating pharmacological effects on NMJ 
transmission.  
To better mimic the intrinsic NMJ milieu, other beneficial factors in addition to electrical 
stimulation can be incorporated, for example, mechanical stimulation, topological manipulation 
and substrate stiffness. Even though 2D culture offers simple and high-throughput platform for 
drug testing, 3D in vitro models can encompass these additional features to further replicate the 
in vivo mechanical and chemical microenvironment capable of facilitating cell maturation and 
neuromuscular function [155, 171, 172]. For instance, a controllable in vitro model of the NMJ 
can be created from encapsulation of both muscle and motoneurons into micropatterned 
hydrogels. We can apply bioengineering techniques to precisely control the factors of interest in 
the cellular environment, including the composition and biomechanics of the hydrogel, geometry 
of patterning and the application patterns of electrical and mechanical stimuli. We hypothesize 
that the provision of an in vivo-like environment directing the organized growth of motoneurons 
and myocytes will enhance functional coupling of the cells and enable quantitative studies of 
regulatory factors, underlying mechanisms and a more physiologically relevant systems for drug 
screening.  
Another aspect of the current models that can be further improved in future studies is an 
integration of microfabricated coculture platform for motoneurons and skeletal muscle to better 
mimic the native environment of NMJ. In the body, motoneurons are morphologically separated 
from, but functionally connected with skeletal muscle. Therefore, we can design the biomimetic 
coculture platform such that axon terminals of motoneurons can interact with myotubes and form 
NMJ, but motoneurons and myotubes are cultured in separate compartments. The potential 
design of the coculture platform is composed of two culture compartments connected to each 
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other through 8 microconduits. The conduits allow only axons of motoneurons to go through 
since the size of the microchannel is smaller than the size of motoneuron cell body (10-20 µm). 
The compartments and microconduits are situated on microelectrode arrays (MEA) substrate 
with multiple electrodes (small blue circles), which can stimulate and record the electrical 
activity of the coculture system. The expected dimension is 2 cm X 2 cm. Having separate 
compartments for motoneurons and myotubes not only mimics the native state, but also allows 
easy monitoring. We can easily locate motoneurons and muscle, and selectively stimulate certain 
type of cells without significantly interfering another. An advantage of MEA substrate and 
multiple electrodes is that non-invasive and multisite stimulation and recording system with 
novel interface circuit modules are possible. This allows not only flexible selection of 
stimulation sites, but also rapid switching of the selected sites between stimulation and 
recording. As a result, almost continuous monitoring of extracellular signals at all the substrate- 
 
Figure 37 Potential design for coculture platform 
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embedded electrodes, including those used for stimulation, is possible. Moreover, the platform 
will be compatible with high-throughput BioMEM (microelectromechanical) devices, enabling 
the integration of this system with the next generation of high-throughput screening 
technologies. 
In our study, cells are derived from mouse, including mESC-derived motoneurons, 
C2C12 myoblast cell line and MEF-derived myocytes. The main reasons for using murine cells 
are the convenience of cell sources, their ability to capture the key functionality of skeletal 
muscle, motoneurons and NMJ, and ease of manipulation, for example, MEFs are more 
amenable to cell reprogramming, compared to human fibroblasts [173]. However, mouse cells 
cannot fully recapitulate the clinical, physiological and biochemical manifestations of human 
cells [174, 175]. The results from mouse models, therefore, might not be accurately predictive of 
responses found in human. Potential factors contributing to possible discrepancy include 
interspecies variations in gene expression, anatomical and physiological differences. 
Nonetheless, mouse models should be able to recapitulate the general characteristics of NMJ and 
provide valuable insights regarding synaptogenesis and neuromuscular transmission.  
To improve the physiological relevance of the model and bridge the gap between 
discovery research and clinical applications, human-based functional model is the logical next 
step and there are multiple potential cell sources. Motoneurons can be derived from stem cells or 
iPS cells of healthy individuals or patients with NMJ-related diseases [41, 176-180] and skeletal 
muscle can be derived from primary cells, satellite cells, stem cells or iPS cells of healthy 
individuals or patients with NMJ-related diseases [40, 173, 181-183]. Multitude of established 
techniques for human cell derivation broaden the versatility of the in vitro models such that they 
can be used in a variety of real-world applications, including drug screening or disease models. 
In the context of SMA, the model of neuromuscular interactions will serve as a basis for several 
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key mechanistic and translational approaches in the future, including extension of the model to 
diseased cells by combining SMA ESC/iPSC-derived motoneurons [41] and primary or 
immortalized muscle cells from SMA biopsies; validation of the relative role of muscles and 
motoneurons in the pathogenesis of SMA, which can be important information for targeting of 
therapeutic agents; testing of drugs, CRISPR/Cas9, microRNA and viral cDNAs/shRNAs for 
their ability to correct the SMA phenotype; and patient-specific disease models and model 
modification to represent different neuromuscular disease models, which will help defining new 
potential therapeutic targets linked to neuromuscular dysfunction. 
In summary, the proposed additional studies to overcome the shortfalls of the current 
cocultures should materially improve and further equip the models with the state-of-the-art 
features of an in vitro NMJ system, such as 3D model [155, 171] that offer better biomimetic 
characteristics, an integration of optogenetic techniques [184], and the use of autologous cells for 
homologous coculture systems, which hold promise for personalized disease therapies [58, 184]. 
All in all, NMJ model is essential for gaining acumen in the development of NMJ, the 
pathogenesis of NMJ-related diseases and the screening of therapeutic candidates. This research 
combined with the continuing progress in the field of genetics and regenerative medicine can 
potentially constitute an important platform in the next generation of cytotoxicity screening, 
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